Stephen Barrett Levine (born 1942) is an American psychiatrist known for his work in human sexuality, particularly sexual dysfunction and transsexualism.

STATE OF WISCONSIN               CIRCUIT COURT               DANE COUNTY

 

 

JOHN and JANE DOE 1, et al.,

Plaintiffs,

Case No. 20-CV- 454

MADISON METROPOLITAN SCHOOL DISTRICT Defendant.

 

EXPERT AFFIDAVIT OF

  1. STEPHEN B. LEVINE, M.D.

 

TABLE OF CONTENTS

  1. CREDENTIALS & SUMMARY OF OPINIONS…………………………………………………………. 1
  2. BACKGROUND ON THE FIELD…………………………………………………………………………….. 6
  3. The biological base-line of sex…………………………………………………………………………….. 6
  4. Definition and diagnosis of gender dysphoria………………………………………………………… 7
  5. Definition of an “expert in the field”……………………………………………………………………. 9
  6. Impact of gender dysphoria on minority and vulnerable groups…………………………….. 11
  7. Three competing conceptual models of gender dysphoria and transgender

identity…………………………………………………………………………………………………………… 11

  1. Four competing models of therapy…………………………………………………………………….. 14
  2. Understanding the WPATH and its “Standards of Care”………………………………………. 19

III.   PATIENTS DIFFER WIDELY AND MUST BE CONSIDERED INDIVIDUALLY……… 22

  1. SOCIAL TRANSITION OF PRE-PUBERTAL CHILDREN IS A MAJOR,

EXPERIMENTAL, AND CONTROVERSIAL PSYCHOTHERAPEUTIC

INTERVENTION THAT SUBSTANTIALLY CHANGES OUTCOMES……………………. 23

  1. PARENTAL INVOLVEMENT IS ESSENTIAL IN MOST CASES FOR ETHICAL

TREATMENT OF A CHILD WHO SUFFERS FROM GENDER DYSPHORIA OR

SEEKS SOCIAL TRANSITION………………………………………………………………………………. 27

  1. Parental involvement is necessary for accurate and thorough diagnosis of the

child and to discern familial and intrapsychic forces that may contribute to

moving the child towards a trans identity……………………………………………………………. 27

  1. Parental involvement is important for effective psychotherapeutic treatment and

support of the child………………………………………………………………………………………….. 30

  1. Parental involvement is necessary to obtain informed consent……………………………….. 31
  2. THE AVAILABLE DATA DOES NOT SUPPORT THE CONTENTION THAT

“AFFIRMATION” OF TRANSGENDER IDENTITY REDUCES SUICIDE OR

RESULTS IN BETTER PHYSICAL OR MENTAL HEALTH OUTCOMES

GENERALLY……………………………………………………………………………………………………….. 32

VII. KNOWN, LIKELY, OR POSSIBLE DOWNSIDE RISKS ATTENDANT ON

MOVING QUICKLY TO “AFFIRM” TRANSGENDER IDENTITY IN

CHILDREN…………………………………………………………………………………………………………… 37

  1. Physical risks associated with transition……………………………………………………………… 38
  2. Social risks associated with transition…………………………………………………………………. 40
  3. Mental health costs or risks……………………………………………………………………………….. 42
  4. Regret following transition is not an infrequent phenomenon………………………………… 43

VIII.   MEDICAL ETHICS & INFORMED CONSENT……………………………………………………. 44

 

 

 

– ii –

 

  1. The obligation of the mental health professional to enable and obtain informed

consent……………………………………………………………………………………………………………. 44

  1. The interests of the patient, as well as necessary disclosures and consent, must

be considered from a life course perspective……………………………………………………….. 47

  1. Special concerns and ethical rules governing experimentation on patients……………….. 48
  2. Ethical principles do not permit using patients as “change agents.”………………………… 48
  3. The inability of children to understand major life issues and risks complicates

informed consent……………………………………………………………………………………………… 49

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

– iii –

 

STATE OF OHIO                  )

) SS

CUYAHOGA COUNTY        )

Stephen B. Levine, being duly sworn, states as follows:

 

  1. CREDENTIALS & SUMMARY OF OPINIONS
  2. I am Clinical Professor of Psychiatry at Case Western Reserve University School

of Medicine, and maintain an active private clinical practice. I received my MD from Case Western Reserve University in 1967, and completed a psychiatric residency at the University Hospitals of Cleveland in 1973. I became an Assistant Professor of Psychiatry at Case Western in 1973, and became a Full Professor in 1985.

  1. Since July 1973 my specialties have included psychological problems and

 

conditions relating to sexuality and sexual relations, therapies for sexual problems, and the

relationship between love and intimate relationships and wider mental health. In 2005, I received
the Masters and Johnson Lifetime Achievement Award from the Society of Sex Therapy and
Research. I am a Distinguished Life Fellow of the American Psychiatric Association.
3. I have served as a book and manuscript reviewer for numerous professional
publications. I have been the Senior Editor of the first (2003), second (2010) and third (2016)
editions of the Handbook of Clinical Sexuality for Mental Health Professionals. In addition to
five other solo-authored books, I have authored Psychotherapeutic Approaches to Sexual
Problems, published in 2020; it has a chapter titled “The Gender Revolution”.

  1. I first encountered a patient suffering what we would now call gender dysphoria
    in July 1973. In 1974, I founded the Case Western Reserve University Gender Identity Clinic,
    and have served as Co-Director of that clinic since that time. Across the years, our Clinic treated
    hundreds of patients who were experiencing a transgender identity. An occasional child was seen
    during this era. I was the primary psychiatric care-giver for several dozen of our patients and

 

supervisor of the work of other therapists. I was an early member of the Harry Benjamin

 

International Gender Dysphoria Association (later known as WPATH) and served as the

Chairman of the Standards of Care Committee that developed the 5th version of its Standards of Care. In 1993 the Gender Identity Clinic was renamed, moved to a new location, and became independent of Case Western Reserve University. I continue to serve as Co-Director.

  1. In 2006, Judge Mark Wolf of the Eastern District of Massachusetts asked me to
    serve as an independent, court-appointed expert in a litigation involving the treatment of a
    transgender inmate within the Massachusetts prison system. I have been retained by the
    Massachusetts Department of Corrections as a consultant on the treatment of transgender inmates
    since 2007.
  2. I was qualified as an expert and testified concerning the diagnosis, understanding,
    developmental paths and outcomes, and therapeutic treatment, of transgenderism and gender
    dysphoria, particularly as it relates to children, in 2019 in the matter of In the Interest of J.A.D.Y.
    and J.U.D.Y., Case No. DF-15-09887-S, 255th Judicial District, Dallas County, TX (the
    “Younger litigation”).
  3. A fuller review of my professional experience, publications, and awards as well as identification of cases in which I have provided expert testimony within the last 13 years, is
    provided in my curriculum vitae, a copy of which is attached hereto as Exhibit A.
  4. In this declaration, I offer, explain, and identify my opinions and the bases for my
    opinions in this matter. Each of the opinions set forth herein is based on my professional
    expertise and experience as described above and I hold each of the opinions set forth herein to a
    reasonable degree of certainty within my field.  The facts upon which I rely are the type of facts
    reasonably relied upon by experts within my field.  A summary of my  opinions is as follows:

 

 

 

– 2 –

 

  1. Sex as defined by biology and reproductive function cannot be changed.

While hormonal and surgical procedures may enable some individuals to “pass” as the opposite gender during some or all of their lives, such procedures carry with them
physical, psychological, and social risks, and no procedures can enable an individual to perform the reproductive role of the opposite sex. (Section II.A.)

  1. The diagnosis of “gender dysphoria” encompasses a diverse array of

conditions, with widely differing pathways and characteristics depending on age of onset among other things.  Data from one population (e.g. adults) cannot be assumed to be applicable to others (e.g. children). (Section II.B.)

  1. Among psychiatrists and psychotherapists who practice in the area, there are currently widely varying views concerning both the causes of and appropriate therapeutic response to gender dysphoria in children. Existing studies do not provide a basis for a scientific conclusion as to which therapeutic response results in the best long-term
    outcomes for affected individuals. (Sections II.E, II.F.)
  2. A majority of children (in several studies, a large majority) who are diagnosed with gender dysphoria “desist”—that is, their gender dysphoria does not persist—by
    puberty or adulthood. It is not currently known how to distinguish children who will
    persist from those who will not. (Section IV.)
  3. Some recent studies suggest that active affirmation of transgender identity in young children will substantially reduce the number of children “desisting” from
    transgender identity. This raises concern that this will increase the number of individuals who suffer the multiple long-term physical, mental, and social limitations that are
    strongly associated with living life as a transgender person. (Section IV.)

 

 

 

– 3 –

 

  1. Thus, social transition is itself an important intervention with profound

 

implications for the long term mental and physical health of the child.  When a mental

health professional evaluates a child or adolescent and then recommends social transition, presumably that professional is available to help with interpersonal, familial, and
psychological problems that may arise.  However, many adolescents transition without mental health assessment and ongoing care, leaving themselves and their families on their own to deal with subsequent problems. (Section IV.)

  1. In most cases, parental involvement is necessary for an accurate and thorough diagnosis of a child or adolescent presenting with gender dysphoria or a desire for a
    transgender identity, as well as for effective psychotherapeutic treatment and support of the young person. (Section V.)
  2. The knowledge-base concerning the cause and treatment of gender dysphoria available today has low scientific quality. (Section VI.)
  3. There are no studies that show that affirmation of transgender identity in
    young children reduces suicide, suicidal ideation, or improves long-term outcomes as
    compared to other therapeutic approaches.  Meanwhile, multiple studies show that adult
    individuals living transgender lives suffer much higher rates of suicide and negative
    physical and mental health conditions than does the general population. (Section VI.)
  4. In light of what is known and not known about the impact of affirmation on the incidence of suicide, suicidal ideation, and other indicators of mental and physical health, it is scientifically baseless and it is unethical to assert that a child or adolescent who express an interest in a transgender identity will kill him- or herself unless adults and peers affirm that child in a transgender identity. (Section VI.)

 

 

 

– 4 –

 

  1. Putting a child or adolescent on a pathway towards life as a transgender

person puts that individual at risk of a wide range of long-term or even life-long harms,
including:  sterilization (whether chemical or surgical) and associated regret and sense of
loss; inability to experience orgasm (for trans women); physical health risks associated
with exposure to elevated levels of cross-sex hormones; surgical complications and life-
long after-care; alienation of family relationships; inability to form healthy romantic
relationships and attract a desirable mate; elevated mental health risks. (Section VII.)

  1. Informed consent is ethically required for potentially life-altering

psychological or medical procedures.  However, the informed consent process is not

simple.  In some cases, it may not be possible to obtain meaningful informed consent to place a child on a psychological pathway that carries with it all the lifetime risks
(including sterilization, limited sexual response, and social marginalization) that I detail in this report.  The child is not competent to weigh how these risks or issues will impact his or her lifetime happiness.  At a minimum, informed consent of parents is essential, although it may not be sufficient. (Section VIII.)

  1. With rare exceptions, educators do not have the professional training and

experience necessary to guide children and parents through the difficult and potentially life-altering decisions surrounding social transition to a transgender identity, nor can they effectively fill the place of parents in the complex process of diagnosis and therapeutic support of children who suffer from gender dysphoria. Educators have a limited time of involvement with their students, whereas the children’s developmental challenges persist as they change grades or schools.  (Section VIII.A.)

 

 

 

 

 

– 5 –

 

  1. BACKGROUND ON THE FIELD
  2. The biological base-line of sex
  3. The sex of a human individual at its core structures the individual’s biological

reproductive capabilities—to produce ova and bear children as a mother, or to produce semen and beget children as a father. Sex determination occurs at the instant of conception, depending on whether a sperm’s X or Y chromosome fertilizes the egg. Medical technology can be used to determine a fetus’s sex before birth. It is thus not literally correct to assert that doctors “assign” the sex of a child at birth; anyone can identify the sex of an infant by genital inspection. What the general public may not understand, however, is that every nucleated cell of an individual’s body is chromosomally identifiably male or female—XY or XX.

  1. The self-perceived gender of a child, in contrast, arises in part from how others
    label the infant: “I love you, son (daughter).” This designation occurs thousands of times in the
    first two years of life when a child begins to show awareness of the two possibilities. As
    acceptance of the designated gender corresponding to the child’s sex is the outcome in >99% of
    children everywhere, anomalous gender identity formation begs for understanding. Is it
    biologically shaped? Is it biologically determined? Is it the product of how the child was
    privately regarded and treated?  Does it stem from trauma-based rejection of maleness or
    femaleness, and if so flowing from what trauma? Is it a symptom of another, as of yet unrevealed
    emotional disturbance? The answers to these relevant questions are not scientifically known.
  2. Under the influence of hormones secreted by the testes or ovaries, numerous
    additional sex-specific differences between male and female bodies continuously develop post-
    natally, culminating in the dramatic maturation of the primary and secondary sex characteristics
    with puberty. These include differences in hormone levels, height, weight, bone mass, shape and
    development, musculature, body fat levels and distribution, and hair patterns, as well as

 

– 6 –

 

physiological differences such as menstruation. These are genetically programmed biological

consequences of sex which also serve to influence the consolidation of gender identity during and after puberty.

  1. Despite the increasing ability of hormones and various surgical procedures to

reconfigure some male bodies to visually pass as female, or vice versa, the biology of the person
remains as defined by his (XY) or her (XX) chromosomes, including cellular, anatomic, and
physiologic characteristics and the particular disease vulnerabilities associated with that
chromosomally-defined sex. For instance, the XX (genetically female) individual who takes
testosterone to stimulate certain male secondary sex characteristics will nevertheless remain
unable to produce sperm and father children. Contrary to assertions and hopes that medicine and
society can fulfill the aspiration of the trans individual to become “a complete man” or “a
complete woman,” this is not biologically attainable.1 It is possible for some adolescents and
adults to pass unnoticed as the opposite gender that they aspire to be—but with limitations, costs,
and risks, as I detail later.

  1. Definition and diagnosis of gender dysphoria
  2. Specialists have used a variety of terms over time, with somewhat shifting

definitions, to identify and speak about a distressing incongruence between an individual’s sex as
determined by their chromosomes and their thousands of genes, and the gender with which they
eventually subjectively identify or to which they aspire. Today’s American Psychiatric
Association Diagnostic and Statistical Manual of Mental Disorders (“DSM-5”) employs the

 

 

 

1 S. Levine (2018), Informed Consent for Transgendered Patients, J. OF SEX & MARITAL THERAPY, at 6, DOI: 10.1080/0092623X.2018.1518885 (“Informed Consent”); S. Levine (2016), Reflections on the Legal Battles Over Prisoners with Gender Dysphoria, J. AM. ACAD.
PSYCHIATRY LAW 44, 236 at 238 (“Reflections”).

 

– 7 –

 

term Gender Dysphoria and defines it with separate sets of criteria for adolescents and adults on

 

the one hand, and children on the other.

 

  1. There are at least five distinct pathways to gender dysphoria: early childhood

onset; onset near or after puberty with no prior cross gender patterns; onset after homosexual life
style; adult onset after years of heterosexual transvestism; and onset in later adulthood with few
or no prior indications of cross-gender tendencies or identity.  The early childhood onset
pathway and the more recently observed onset around puberty pathway are relevant to this
matter.

  1. Gender dysphoria has very different characteristics depending on age and sex at
    onset. Young children who are living a transgender identity commonly suffer materially fewer
    symptoms of concurrent mental distress than do older patients.2 The developmental and mental
    health patterns for each of these groups are sufficiently different that data developed in
    connection with one of these populations cannot be assumed to be applicable to another. (Id. at

9.)

  1. The criteria used in DSM-5 to identify Gender Dysphoria include a number of signs of discomfort with one’s natal sex and vary somewhat depending on the age of the patient, but in all cases require “clinically significant distress or impairment in . . . important areas of functioning” such as social, school, or occupational settings.
  2. When these criteria in children, (or adolescents, or adults) are not met, two other
    diagnoses may be given. These are: Other Specified Gender Dysphoria and Unspecified Gender

 

 

 

2 K. Zucker (2018), The Myth of Persistence: Response to “A Critical Commentary on Follow-Up Studies & ‘Desistance’ Theories about Transgender & Gender Non-Conforming Children” by Temple Newhook et al., INT’L J. OF TRANSGENDERISM at 10, DOI:

10.1080/15532739.2018.1468293 (“Myth of Persistence”).

 

– 8 –

 

Dysphoria. Specialists sometimes refer to children who do not meet criteria as being

 

“subthreshold.”

  1. Children who conclude that they are transgender are often unaware of a vast array of adaptive possibilities for how to live life as a man or a woman—possibilities that become increasingly apparent over time to both males and females. A boy or a girl who claims or
    expresses interest in pursuing a transgender identity often does so based on stereotypical notions of femaleness and maleness that are based on constrictive notions of what men and women can be.3 A young child’s—or even adolescent’s—understanding of this topic is quite limited. Nor do they have the perspective that discomfort with the body and perceived social role is not new to civilization; what is new is the option to become a trans person.
  2. Definition of an “expert in the field”
  3. In my opinion, in order to be considered an expert qualified to diagnose a child or

adolescent who may suffer from gender dysphoria or related conditions, or to advise or opine on
therapy options, and associated risks and benefits, for children and adolescents presenting with
gender-related issues, a healthcare professional should have at least the following qualifications:

  1. Enough knowledge of child development to be able to elicit relevant

information by history about situation of the pregnancy (wanted, natural, reproductively-
assisted), maternal health during pregnancy, health of the child from birth on, timing of
the attainment of pediatric developmental milestones, immediately apparent and later
revealed congenital abnormalities, parental relationship, post-partum depression,
influence of other children in the family, and onset and progression of the cross-gender
behavior. It is to be expected that the clinician be able to ask about what was happening

3 S. Levine (2017), Ethical Concerns About Emerging Treatment Paradigms for Gender Dysphoria,  J. OF SEX & MARITAL THERAPY at 7, DOI: 10.1080/0092623X.2017.1309482
(“Ethical Concerns”).

 

– 9 –

 

between parents and child and between parents shortly before the onset of cross-gender

 

behaviors (Levine (2018), Informed Consent at 8);

  1. The ability to discern attitudes towards homosexuality in parents and grandparents;
  2. A familiarity with the controversies concerning ethical considerations surrounding possible interventions in the life of a child and family affected by transgenderism;4
  3. An understanding of the literature concerning developmental influences on children’s gender dysphoria including sensitivity to autistic spectrum influences;
  4. Ability to recognize, identify, and treat psychiatric co-morbidities;
  5. Experience with psychiatric adolescent outcomes in terms of psychiatric symptoms, orientation, and social problems;
  6. An awareness of the negative as well as the positive potential short- and longterm impacts of alternative interventions on the patient and his or her family;
  7. Regular reading of journal articles about the treatment of children and adolescents with gender dysphoria;
  8. Knowledge of the literature concerning both persistence and desistance of gender dysphoria in children.
  9. It is not realistic to expect educators or school counselors to have these

 

qualifications.  They are the result of professional training followed by intense concentrated

experience with patients with mental illness, developmental difficulties short of serious mental illness, and working with the psychodynamics of individual and family lives.

 

4 K. Zucker (2019), Debate: Different Strokes for Different Folks, CHILD & ADOLESCENT MENTAL HEALTH, at 1-2, DOI: 10.1111/camh.12330 (“Debate”).

 

– 10 –

 

  1. Impact of gender dysphoria on minority and vulnerable groups
  2. In considering the appropriate response to gender dysphoria, it is important to

know that certain groups of children have an increased prevalence and incidence of trans

identities.  These include: children of color,5 children with mental developmental disabilities,6 including children on the autistic spectrum (at a rate more than 7x the general population),7 children residing in foster care homes, adopted children (at a rate more than 3x the general population),8 children with a prior history of psychiatric illness,9 and more recently adolescent girls (in a large recent study, at a rate more than 2x that of boys). (G. Rider at 4.)

  1. Three competing conceptual models of gender dysphoria and transgender

identity

  1. Discussions about appropriate responses by mental health professionals (“MHPs”)
    to actual or sub-threshold gender dysphoria are complicated by the fact that various speakers and

5 G. Rider et al. (2018), Health and Care Utilization of Transgender/Gender Non-

Conforming Youth: A Population Based Study, PEDIATRICS at 4, DOI: 10.1542/peds.2017-1683.
(In a large sample, non-white youth made up 41% of the set who claimed a transgender or
gender-nonconforming identity, but only 29% of the set who had a gender identity consistent
with their sex.)

6 D. Shumer & A. Tishelman (2015), The Role of Assent in the Treatment of Transgender Adolescents, INT. J. TRANSGENDERISM at 1, DOI: 10.1080/15532739.2015.1075929.

7 D. Shumer et al. (2016), Evaluation of Asperger Syndrome in Youth Presenting to a Gender Dysphoria Clinic, LGBT HEALTH, 3(5) 387 at 387.

8 D. Shumer et al. (2017), Overrepresentation of Adopted Adolescents at a HospitalBased Gender Dysphoria Clinic, TRANSGENDER HEALTH Vol. 2(1) 76 at 77.

9 L. Edwards-Leeper et al. (2017), Psychological Profile of the First Sample of

Transgender Youth Presenting for Medical Intervention in a U.S. Pediatric Gender Center,

PSYCHOLOGY OF SEXUAL ORIENTATION AND GENDER DIVERSITY, 4(3) 374 at 375

(“Psychological Profile”); R. Kaltiala-Heino et al. (2015), Two Years of Gender Identity Service
for Minors: Overrepresentation of Natal Girls with Severe Problems in Adolescent Development,
CHILD & ADOLESCENT PSYCHIATRY & MENTAL HEALTH 9(9) 1 at 5. (In 2015 Finland gender
identity service statistics, 75% of adolescents assessed “had been or were currently undergoing
child and adolescent psychiatric treatment for reasons other than gender dysphoria.”); L. Littman
(2018), Parent Reports of Adolescents & Young Adults Perceived to Show Signs of a Rapid
Onset of Gender Dysphoria, PLoS ONE 13(8): e0202330 at 13 (Parental survey concerning
adolescents exhibiting Rapid Onset Gender Dysphoria reported that 62.5% of gender dysphoric
adolescents had “a psychiatric disorder or neurodevelopmental disability preceding the onset of
gender dysphoria.”

 

– 11 –

 

advocates (or a single speaker at different times) view transgenderism through at least three very

different paradigms, often without being aware of, or at least without acknowledging, the distinctions.

  1. Gender dysphoria is conceptualized and described by some professionals and
    laypersons as though it were a serious, physical medical illness that causes suffering,
    comparable, for example, to prostate cancer, a disease that is curable before it spreads. Within
    this paradigm, whatever is causing distress associated with gender dysphoria—whether
    secondary sex characteristics such as facial hair, nose and jaw shape, presence or absence of
    breasts, or the primary anatomical sex organs of testes, ovaries, penis, or vagina—should be
    removed to alleviate the illness. The promise of these interventions is the cure of the gender
    dysphoria.
  2. It should be noted, however, that gender dysphoria is a psychiatric rather than a medical diagnosis. Since its inception in DSM-III, it has always and only been specified in the psychiatric DSM manuals. Notably, gender dysphoria is the only psychiatric condition to be treated by surgery, even though no endocrine or surgical intervention package corrects any identified biological abnormality. (Levine, Reflections, at 240.)
  3. Gender dysphoria is alternatively conceptualized in developmental terms, as an
    adaptation to a psychological problem that was first manifested as a failure to establish a
    comfortable conventional sense of self in early childhood. This paradigm starts from the premise
    that all human lives are influenced by past processes and events. Trans lives are not exceptions to
    this axiom. (Levine, Reflections, at 238.) MHPs who think of gender dysphoria through this
    paradigm may work both to identify and address causes of the basic problem of the deeply
    uncomfortable self, and also to ameliorate suffering when the underlying problem cannot be

 

 

 

– 12 –

 

solved. They work with the patient and (ideally) family to inquire what forces may have led to

the trans person repudiating the gender associated with his sex. The developmental paradigm is
mindful of temperamental, parental bonding, psychological, sexual, and physical trauma
influences, and the fact that young children work out their psychological issues through fantasy
and play.

  1. In addition, the developmental paradigm recognizes that, with the important

 

exception of genetic sex, essentially all aspects of an individual’s identity evolve—often

markedly—across the individual’s lifetime. This includes gender. While some advocates assert
that a transgender identity is biologically caused, fixed from early life, and eternally present in an
unchanging manner, this is not supported by science. Although numerous studies have been
undertaken to attempt to demonstrate a distinctive physical brain structure associated with
transgender identity, as of yet there is no evidence that these patients have any defining
abnormality in brain structure that precedes the onset of gender dysphoria. The belief that gender
dysphoria is the consequence of brain structure is challenged by the sudden increase in incidence
of child and adolescent gender dysphoria over the last twenty years in North America and
Europe. Meanwhile, multiple studies have documented rapid shifts in gender ratios of patients
presenting for care with gender-related issues, pointing to cultural influences,10 while a recent
study documented “clustering” of new presentations in specific schools and among specific
friend groups, pointing to social influences (Littman). Both of these findings strongly suggest
cultural factors. From the beginning of epidemiological research into this arena, there have
always been some countries, Poland and Australia, for example, where the sex ratios were

 

 

10 Levine, Ethical Concerns, at 8 (citing M. Aitken, T. D. Steensma, et al. (2015),

Evidence for an Altered Sex Ratio in Clinic-Referred Adolescents with Gender Dysphoria, J. OF SEXUAL MEDICINE 12(3) 756 at 756-63).

 

– 13 –

 

reversed as compared to North America and Europe, again demonstrating a powerful effect of

 

cultural influences.

 

  1. In recent years, for adolescent patients, intense involvement with online

transgender communities or “friends” is the rule rather than the exception, and the MHP will also
be alert to this as a potentially significant influence on the identity development of the patient.

  1. The third paradigm through which gender dysphoria is alternatively

conceptualized is from a sexual minority rights perspective. Under this paradigm, any response
other than medical and societal affirmation and implementation of a patient’s claim to “be” the
opposite gender is a violation of the individual’s civil right to self-expression. Any effort to ask
“why” questions about the patient’s condition, or to address underlying causes, is viewed as a
violation of autonomy and civil rights.  In the last few years, this paradigm has been successful
in influencing public policy and the education of pediatricians, endocrinologists, and many
mental health professionals.

  1. Four competing models of therapy
  2. Because of the complexity of the human psyche and the difficulty of running

controlled experiments in this area, substantial disagreements among professionals about the

causes of psychological disorders, and about the appropriate therapeutic responses, are not

 

unusual. When we add to this the very different paradigms for understanding transgender

phenomena discussed above, it is not surprising that such disagreements also exist with regard to appropriate therapies for patients experiencing gender-related distress. I summarize below the leading approaches, and offer certain observations and opinions concerning them.

(1)       The “watchful waiting” therapy model

 

 

 

 

 

– 14 –

 

  1. I review below the uniform finding of follow-up studies that the large majority of

children who present with gender dysphoria will desist from desiring a transgender identity by adulthood if left untreated. (See infra ¶ 60.)

  1. When a pre-adolescent child presents with gender dysphoria, a “watchful waiting”
    approach seeks to allow for the fluid nature of gender identity in children to naturally evolve—
    that is, take its course from forces within and surrounding the child. Watchful waiting has two
    versions:
  2. Treating any other psychological co-morbidities—that is, other mental

illnesses as defined by the DSM—that the child may exhibit (separation anxiety,

bedwetting, attention deficit disorder, obsessive-compulsive disorder) without a focus on gender (model #1), and

  1. No treatment at all for anything, but a regular follow-up appointment. This might be labeled a “hands off” approach (model #2).

(2)       The psychotherapy model: Alleviate distress by identifying and

addressing causes (model #3)

  1. One of the foundational principles of psychotherapy has long been to work with a patient to identify the causes of observed psychological distress and then to address those causes as a means of alleviating the distress. The National Institute of Mental Health has promulgated the idea that 75% of adult psychopathology has its origins in childhood experience.
  2. Many experienced practitioners in the field of gender dysphoria, including myself,
    have believed that it makes sense to employ these long-standing tools of psychotherapy for
    patients suffering gender dysphoria, asking the question as to what factors in the patient’s life are
    the determinants of the patient’s repudiation of his or her natal sex. (Levine, Ethical Concerns, at

8.) I and others have reported success in alleviating distress in this way for at least some patients,

 

 

– 15 –

 

whether or not the patient’s sense of discomfort or incongruence with his or her natal sex entirely

disappeared. Relieving accompanying psychological co-morbidities leaves the patient freer to consider the pros and cons of transition as he or she matures.

  1. Among other things, the psychotherapist who is applying traditional methods of
    psychotherapy may help—for example—the male patient appreciate the wide range of masculine
    emotional and behavioral patterns as he grows older. He may discuss with his patient, for
    example, that one does not have to become a “woman” in order to be kind, compassionate,
    caring, noncompetitive, and devoted to others’ feelings and needs.11 Many biologically male
    trans individuals, from childhood to older ages, speak of their perceptions of femaleness as
    enabling them to discuss their feelings openly, whereas they perceive boys and men to be
    constrained from emotional expression within the family and larger culture. Men, of course, can
    be emotionally expressive, just as they can wear pink. Converse examples can be given for girls
    and women. These types of ideas regularly arise during psychotherapies.
  2. As I note above, many gender-nonconforming children and adolescents in recent
    years derive from minority and vulnerable groups who have reasons to feel isolated and have an
    uncomfortable sense of self. A trans identity may be a hopeful attempt to redefine the self in a
    manner that increases their comfort and decreases their anxiety. The clinician who uses
    traditional methods of psychotherapy may not focus on their gender identity, but instead work to
    help them to address the actual sources of their discomfort.  Success in this effort may remove or
    reduce the desire for a redefined identity. This often involves a focus on disruptions in their
    attachment to parents in vulnerable children, for instance, those in the foster care system.

 

 

 

11 S. Levine (2017), Transitioning Back to Maleness, ARCH. OF SEXUAL BEHAVIOR at 7, DOI: 10.1007/s10508-017-1136-9) (“Transitioning”).

 

– 16 –

 

  1. Because “watchful waiting” can include treatment of accompanying

psychological co-morbidities, and the psychotherapist who hopes to relieve gender dysphoria may focus on potentially causal sources of psychological distress rather than on the gender
dysphoria itself, there is no sharp line between “watchful waiting” and the psychotherapy model in the case of prepubescent children.

  1. To my knowledge, there is no evidence beyond anecdotal reports that

psychotherapy can enable a return to male identification for genetically male boys, adolescents, and men, or return to female identification for genetically female girls, adolescents and women. On the other hand, anecdotal evidence of such outcomes does exist; I and other clinicians have witnessed reinvestment in the patient’s biological sex in some individual patients who are
undergoing psychotherapy. The Internet contains many such reports, and I have published a paper recently on a patient who sought my therapeutic assistance to reclaim his male gender identity after 30 years living as a woman and is in fact living as a man today. (Levine,
Transitioning, at 1.) I have seen children desist even before puberty in response to thoughtful parental interactions and a few meetings of the child with a therapist.

(3)       The affirmation therapy model (model #4)

  1. While it is widely agreed that the therapist should not directly challenge a claimed

transgender identity in a child, some advocates and practitioners go much further, and promote
and recommend that any expression of transgender identity should be immediately accepted as
decisive, and thoroughly affirmed by means of consistent use of clothing, toys, pronouns, etc.
associated with transgender identity. These advocates treat any question about the causes of the
child’s transgender identification as inappropriate, and assume that observed psychological co-
morbidities in the children or their families are unrelated or will get better with transition, and

 

 

 

– 17 –

 

need not be addressed by the MHP who is providing supportive guidance concerning the child’s

 

gender identity.

  1. Some advocates, indeed, assert that unquestioning affirmation of any claim of
    transgender identity in children is essential, and that the child will otherwise face a high risk of
    suicide or severe psychological damage. I address claims about suicide and health outcomes in
    Section VI below.
  2. Some advocates also assert that this “affirmation therapy” model is accepted and agreed with by the overwhelming majority of mental health professionals. However, one
    respected academic in the field has recently written that, on the contrary, “almost all clinics and professional associations in the world” do not use “gender affirmation” for prepubescent children and instead “delay any transitions after the onset of puberty.”12
  3. Even the Standards of Care published by WPATH, an organization which in

general leans strongly towards affirmation in the case of adults, does not specify affirmation of transgender identity as the indicated therapeutic response for young children, but rather calls for a careful process of discernment and decision specific to each child, by the family in consultation with the mental health professional.

  1. Further, the DSM-5 added—for both children and adolescents—a requirement
    that a sense of incongruence between biological and felt gender must last at least six months as a

 

 

 

 

 

 

 

 

12 J. Cantor (2019), Transgender and Gender Diverse Children and Adolescents:  FactChecking of AAP Policy, J. OF SEX & MARITAL THERAPY at 1, DOI:

10.1080.0092623X.2019.1698481.

 

– 18 –

 

precondition for a diagnosis of gender dysphoria, precisely because of the risk of “transitory”

 

symptoms and “hasty” diagnosis that might lead to “inappropriate” treatments.13

  1. I do not know what proportion of practitioners are using which model. However, in my opinion, in the case of young children, prompt and thorough affirmation of a transgender identity disregards the principles of child development and family dynamics, and is not
    supported by science. Rather, the MHP must focus attention on the child’s underlying internal and familial issues. Ongoing relationships between the MHP and the parents and the MHP and the child are vital to help the parents, child, other family members, and the MHP to understand over time the issues that need to be dealt with over time by each of them.
  2. Likewise, since the child’s sense of gender develops in interaction with his

parents and their own gender roles and relationships, the responsible MHP will almost certainly need to delve into family and marital dynamics.

  1. Understanding the WPATH and its “Standards of Care”
  2. In almost any discussion of the diagnosis and care of patients suffering gender

dysphoria or exhibiting transgender characteristics, the World Professional Association for

Transgender Health (WPATH) and the Standards of Care that that organization publishes will be mentioned. Accordingly, I provide some context concerning that private organization.

  1. I was a member of the Harry Benjamin International Gender Dysphoria

Association from 1974 until 2001. From 1997 through 1998, I served as the Chairman of the
eight-person International Standards of Care Committee that issued the fifth version of the
Standards of Care. I resigned my membership in 2002 due to my regretful conclusion that the
organization and its recommendations had become dominated by politics and ideology, rather

13 K. Zucker (2015), The DSM-5 Diagnostic Criteria for Gender Dysphoria, in C. Trombetta et al. (eds.), MANAGEMENT OF GENDER DYSPHORIA: A MULTIDISCIPLINARY APPROACH, DOI 10.1007/978-88-470-5696-1_4 (Springer-Verlag Italia 2015).

 

– 19 –

 

than by scientific process, as it was years earlier. In approximately 2007, the Henry Benjamin

International Gender Dysphoria Association changed its name to the World Professional Association for Transgender Health.

  1. WPATH is a voluntary membership organization. Since at least 2002, attendance
    at its biennial meetings has been open to trans individuals who are not licensed professionals.
    While this ensures taking patients’ needs into consideration, it limits the ability for honest and
    scientific debate, and means that WPATH can no longer be considered a purely professional
    organization.
  2. WPATH takes a decided view on issues as to which there is a wide range of

 

opinion among professionals. WPATH explicitly views itself as not merely a scientific

organization, but also as an advocacy organization. (Levine, Reflections, at 240.) WPATH is

supportive to those who want sex reassignment surgery (“SRS”). Skepticism as to the benefits of
SRS to patients, and strong alternate views, are not well tolerated in discussions within the
organization. Such views have been known to be shouted down and effectively silenced by the
large numbers of nonprofessional adults who attend the organization’s biennial meetings.

  1. The Standards of Care (“SOC”) is the product of an enormous effort to be

 

balanced, but it is not a politically neutral document. WPATH aspires to be both a scientific

organization and an advocacy group for the transgendered. These aspirations sometimes conflict. The limitations of the Standards of Care, however, are not primarily political. They are caused by the lack of rigorous research in the field which allows room for passionate convictions on how to care for the transgendered.

  1. In recent years, WPATH has fully adopted some mix of the medical and civil

 

rights paradigms. It has downgraded the role of counseling or psychotherapy as a requirement for

 

 

 

– 20 –

 

these life-changing processes. WPATH no longer considers preoperative psychotherapy to be a

requirement. It is important to WPATH that the person has gender dysphoria; the pathway to the development of this state is not. (Levine, Reflections, at 240.) The trans person is assumed to have thoughtfully considered his or her options before seeking hormones, for instance.

  1. Most psychiatrists and psychologists who treat patients suffering sufficiently

severe distress from gender dysphoria to seek inpatient psychiatric care are not members of

 

WPATH. Many psychiatrists and psychologists who treat some patients suffering gender

dysphoria on an outpatient basis are not members of WPATH. WPATH represents a self-selected
subset of the profession along with its many non-professional members; it does not capture the
clinical experiences of others. WPATH claims to speak for the medical profession; however, it
does not welcome skepticism and therefore, deviates from the philosophical core of medical
science.

  1. For example, in 2010 the WPATH Board of Directors issued a statement

advocating that incongruence between sex and felt gender identity should cease to be identified in the DSM as a pathology.14 This position was debated but not adopted by the (much larger) American Psychiatric Association, which maintained the definitions and diagnoses of gender dysphoria as a pathology in the DSM-5 manual issued in 2013.

  1. In my experience most current members of WPATH have little ongoing

experience with the mentally ill, and many trans care facilities are staffed by MHPs who are not
deeply experienced with recognizing and treating frequently associated psychiatric co-
morbidities. Because the 7th version of the WPATH SOC deleted the requirement for therapy,
trans care facilities that consider these Standards sufficient are permitting patients to be

 

14 WPATH De-Psychopathologisation Statement (May 26, 2010), available at wpath.org/policies (last accessed January 21, 2020).

 

– 21 –

 

counseled to transition by means of social presentation, hormones, and surgery by individuals

 

with masters rather than medical degrees. As a result of the downgrading of the role of the

 

psychiatric assessment of patients, new “gender affirming” clinics have arisen in many urban

settings that quickly (sometimes within an hour’s time) recommend transition. Concerned

parents who came wanting to know what is going on in their children are overwhelmed, and feel
disoriented, fearful for the health and safety of their children, and dependent on the professional.

III.      PATIENTS DIFFER WIDELY AND MUST BE CONSIDERED INDIVIDUALLY.

  1. In my opinion, it is not possible to make a single, categorical statement about the

proper treatment of children presenting with gender dysphoria or other gender-related issues.

Indeed, an MHP cannot responsibly opine on the proper treatment of a particular child presenting
with gender dysphoria unless and until he or she has had more than one working session with
that child, and has taken a thorough developmental history of the child’s gender-related issues
(or has reviewed such a history prepared by another MHP). This is so for multiple reasons.

  1. There is no single pathway of development and outcomes governing transgender identity, nor one that predominates over the large majority of cases. Instead, as individuals grow up and age, depending on their differing psychological, social, familial, and life experiences, their outcomes differ widely.
  2. As to causes in children, details about the onset of gender dysphoria may be found in an understanding of family relationship dynamics. In particular, the relationship between the parents and each of the parents and the child, and each of the siblings and the child should be
    well known by the MHP.
  3. Further, a disturbingly large proportion of children who seek professional care in
    connection with gender issues have a wider history of psychiatric co-morbidities. (See supra n.

9.) A 2017 study from the Boston Children’s Hospital Gender Management Service program

 

– 22 –

 

reported that: “Consistent with the data reported from other sites, this investigation documented

that 43.3% of patients presenting for services had significant psychiatric history, with 37.1% having been prescribed psychotropic medications, 20.6% with a history of self-injurious behavior, 9.3% with a prior psychiatric hospitalization, and 9.3% with a history of suicide attempts.” (L. Edwards-Leeper, Psychological Profile, at 375.) It seems likely that an even higher proportion will have had prior undiagnosed psychiatric conditions.

  1. As to outcomes, as I explain below, for pre-pubertal children, desistance from transgender identification in favor of a gender corresponding to the child’s sex, during or within a few years of puberty, is a likely outcome absent intervention. (Infra Section IV.)
  2. Because the causes, characteristics, social and relational context, and likely future
    course of gender dysphoria vary widely from individual to individual, it is essential that the MHP
    spend significant time with an individual patient over multiple sessions to take a careful
    developmental history, before attempting to decide on a course of therapy for that individual.
  3. SOCIAL TRANSITION OF PRE-PUBERTAL CHILDREN IS A MAJOR,

EXPERIMENTAL, AND CONTROVERSIAL PSYCHOTHERAPEUTIC
INTERVENTION THAT SUBSTANTIALLY CHANGES OUTCOMES.

  1. A distinctive and critical characteristic of juvenile gender dysphoria is that

multiple studies from separate groups and at different times have reported that in the large

majority of patients, absent a substantial intervention such as social transition and/or hormone
therapy, it does not persist through puberty. A recent article reviewed all existing follow-up
studies that the author could identify of children diagnosed with gender dysphoria (11 studies),
and reported that “every follow-up study of GD children, without exception, found the same
thing: By puberty, the majority of GD children ceased to want to transition.” (Cantor at 1.)
Another author reviewed the existing studies and reported that in “prepubertal boys with gender
discordance . . . the cross gender wishes usually fade over time and do not persist into adulthood,

 

– 23 –

 

with only 2.2% to 11.9% continuing to experience gender discordance.”15 A third summarized

the existing data as showing that “Symptoms of GID at prepubertal ages decrease or disappear in a considerable percentage of children (estimates range from 80-95%).”16

  1. It is not yet known how to distinguish those children who will desist from that small minority whose trans identity will persist. (Levine, Ethical Concerns, at 9.)17
  2. Desistance within a relatively short period may also be a common outcome for
    post-pubertal youths who exhibit recently described “rapid onset gender disorder.” I observe an
    increasingly vocal online community of young women who have reclaimed a female identity
    after claiming a male gender identity at some point during their teen years. However, data on
    outcomes for this age group with and without therapeutic interventions is not yet available to my
    knowledge.
  3. In contrast, there is now data that suggests that a therapy that encourages social
    transition dramatically changes outcomes. A prominent group of authors has written that “The
    gender identity affirmed during puberty appears to predict the gender identity that will persist
    into adulthood.”18 Similarly, a comparison of recent and older studies suggests that when an
    “affirming” methodology is used with children, a substantial proportion of children who would

 

 

 

15 S. Adelson & American Academy of Child & Adolescent Psychiatry (2012), Practice Parameter on Gay, Lesbian, or Bisexual Sexual Orientation, Gender Nonconformity, and
Gender Discordance in Children and Adolescents, J. AM. ACAD. CHILD ADOLESCENT
PSYCHIATRY 51(9) 957 at, 963 (“Practice Parameter”).

16 P. T. Cohen-Kettenis, H. A. Delemarre-van de Waal et al. (2008), The Treatment of Adolescent Transsexuals: Changing Insights, J. SEXUAL MEDICINE 5(8) 1892 at 1895.

17 It is also apparent in the adolescent phenomenon of rapid onset of gender dysphoria

following a gender normative childhood that childhood gender identity is not inherently stable in either direction.

18 C. Guss et al. (2015), Transgender and Gender Nonconforming Adolescent Care: Psychosocial and Medical Considerations, CURR. OPIN. PEDIATR. 26(4) 421 at 421 (“TGN Adolescent Care”).

 

– 24 –

 

otherwise have desisted by adolescence—that is, achieved comfort identifying with their natal

 

sex—instead persist in a transgender identity. (Zucker, Myth of Persistence, at 7.)19

 

  1. Indeed, a review of multiple studies of children treated for gender dysphoria

across the last three decades found that early social transition to living as the opposite sex

severely reduces the likelihood that the child will revert to identifying with the child’s natal sex,
at least in the case of boys. That is, while, as I review above, studies conducted before the
widespread use of social transition for young children reported desistance rates in the range of
80-98%, a more recent study reported that fewer than 20% of boys who engaged in a partial or
complete social transition before puberty had desisted when surveyed at age 15 or older. (Zucker,
Myth of Persistence, at 7; Steensma (2013).)20 Some vocal practitioners of prompt affirmation
and social transition even claim that essentially no children who come to their clinics exhibiting
gender dysphoria or cross-gender identification desist in that identification and return to a gender
identity consistent with their biological sex.21 This is a very large change as compared to the
desistance rates documented apart from social transition. Some researchers who generally

 

 

 

 

 

19 One study found that social transition by the child was found to be strongly correlated with persistence for natal boys, but not for girls. (Zucker, Myth of Persistence, at 5 (citing T.D. Steensma, J.K. McGuire et al. (2013), Factors Associated with Desistance & Persistence of
Childhood Gender Dysphoria: A Qualitative Follow-up Study, J. OF THE AM. ACAD. OF CHILD & ADOLESCENT PSYCHIATRY 52, 582.).)

20 Only 2 (3.6%) of 56 of the male desisters observed by Steensma et al. had made a

complete or partial transition prior to puberty, and of the twelve males who made a complete or partial transition prior to puberty, only two had desisted when surveyed at age 15 or older.
Steensma (2013) at 584.

21 See, e.g., B. Ehrensaft (2015), Listening and Learning from Gender-Nonconforming Children, THE PSYCHOANALYTIC STUDY OF THE CHILD 68(1) 28 at 34:  “In my own clinical
practice . . . of those children who are carefully assessed as transgender and who are allowed to transition to their affirmed gender, we have no documentation of a child who has ‘desisted’ and asked to return to his or her assigned gender.”

 

– 25 –

 

advocate prompt affirmation and social transition also acknowledge a causal connection between

 

social transition and this change in outcomes.22

  1. Accordingly, I agree with a noted researcher in the field who has written that
    social transition in children must be considered “a form of psychosocial treatment.” (Zucker,
    Debate, at 1.)
  2. So far as I am aware, no study yet reveals whether the life-course mental and

physical health outcomes for this relatively new class of “persisters” are more similar to those of the general non-transgender population, or to the notably worse outcomes exhibited by the
transgender population generally.

  1. However, I agree with Zucker who has written, “…we cannot rule out the

possibility that early successful treatment of childhood GID [Gender Identity Disorder] will

diminish the role of a continuation of GID into adulthood. If so, successful treatment would also
reduce the need for the long and difficult process of sex reassignment which includes hormonal
and surgical procedures with substantial medical risks and complications.”23 By the same token,
a therapeutic methodology for children that increases the likelihood that the child will continue
to identify as the opposite gender into adulthood will increase the need for the long and
potentially problematic processes of hormonal and genital and cosmetic surgical procedures.

  1. Not surprisingly, given these facts, encouraging social transition in children
    remains controversial. Supporters of such transition acknowledge that “Controversies among

 

22 See Guss, TGN Adolescent Care, at 2. “The gender identity affirmed during puberty appears to predict the gender identity that will persist into adulthood.”  “Youth with persistent TNG [transgender, nonbinary, or gender-nonconforming] identity into adulthood . . . are more likely to have experienced social transition, such as using a different name . . . which is
stereotypically associated with another gender at some point during childhood.”

23 Zucker, Myth of Persistence, at 8 (citing H. Meyer-Bahlburg (2002), Gender Identity Disorder in Young Boys: A Parent- & Peer-Based Treatment Protocol, CLINICAL CHILD
PSYCHOLOGY & PSYCHIATRY 7, 360 at 362.).

 

– 26 –

 

providers in the mental health and medical fields are abundant . . . These include differing

assumptions regarding . . . the age at which children . . . should be encouraged or permitted to socially transition……………….. These are complex and providers in the field continue to be at odds in their efforts to work in the best interests of the youth they serve.”24

  1. In sum, therapy for young children that encourages transition cannot be

considered to be neutral, but instead is an experimental procedure that has a high likelihood of
changing the life path of the child, with highly unpredictable effects on mental and physical
health, suicidality, and life expectancy. Claims that a civil right is at stake do not change the fact
that what is proposed is a social and medical experiment. (Levine, Reflections, at 241.) Ethically,
then, it should be undertaken only subject to standards, protocols, and reviews appropriate to
such experimentation.

  1. PARENTAL INVOLVEMENT IS ESSENTIAL IN MOST CASES FOR ETHICAL

TREATMENT OF A CHILD WHO SUFFERS FROM GENDER DYSPHORIA OR SEEKS SOCIAL TRANSITION.

  1. For many reasons, in the large majority of cases the involvement of one or both
    parents will be essential to a responsible, effective, and indeed ethical diagnosis and treatment of
    a child who is or may be suffering from gender dysphoria or one of the related conditions I have
    described above.
  2. Parental involvement is necessary for accurate and thorough diagnosis of the

child and to discern familial and intrapsychic forces that may contribute to moving the child towards a trans identity.

  1. A claim or expression of interest in a transgender identity by a child must be the
    beginning, not the end, of a careful diagnostic and therapeutic process. Transgender
    identification in a child is not a simple, uniform phenomenon; as I have explained, there is no

 

24 A. Tishelman et al. (2015), Serving Transgender Youth: Challenges, Dilemmas and
Clinical Examples, PROF. PSYCHOL. RES. PR. at 11, DOI: 10.1037/a0037490 (“Serving TG
Youth”).

 

– 27 –

 

single pathway of development and outcomes governing transgender identity, nor one that

 

predominates over the large majority of cases. Instead, as individuals grow up and age,

depending on their differing psychological, social, familial, and life experiences, their outcomes differ widely.

  1. What can be observed by—for example—a teacher or counselor at school,

although important, is only one window into the life and psyche of a child.  A teacher’s

perspective emphasizes learning capacities, social interactions, and gender style relative to other similarly aged children, often during just one school year.

  1. As a starting point, any child suffering serious tension between his or her

reproductive biology and sense of gender identity (or desired gender identity) should have the assistance and support of a skilled mental health professional, and a meaningful diagnosis of the child’s condition will require a sustained relationship between an MHP and the child over time. The involvement of parents will often be essential to establishing and maintaining this type of relationship between an MHP and the child.

  1. What the child means by a claim of transgender identity may vary widely

depending on age. Younger grade school children, for example, have some concept of gender,
but what they “know” about the sexes, about the future meaning of male or female, or about
gender identity—beyond what they are told by adults or what they pick up unconsciously from
mother, father, siblings, and extended family—is limited. Thus, one sees children draw
distinctions in colors, clothing, and toys—classic early stereotypes of what it means to be a girl
or a boy.

 

 

 

 

 

 

 

– 28 –

 

  1. The child may or may not actually suffer from gender dysphoria, and this should

be determined. 25 Input from parents is likely to be important to evaluating whether a child is

suffering from “clinically significant distress or impairment in social, school, or other important areas of functioning.” (DSM-5)

  1. Parents, similarly, in many cases will have observed the child over his or her

entire lifetime, and so will have unique insight into whether the child’s attraction to a transgender identity is longstanding and stable, or whether on the contrary it has been abrupt and associated with intensive online interaction with transgender “communities.”

  1. Likewise, when parental or family dynamics play a role in the child’s discomfort with his or her natal sex (see supra ¶ 56), it will not be possible to evaluate these influences without parental involvement in the diagnostic and therapeutic process. A thorough evaluation cannot be done as effectively in a short period. Ideally a long-term relationship with parents enables a clear picture of what happened in the family and to the child because a different level of trust often occurs over time between the parents and the MHP.
  2. In addition, as I detail elsewhere, a large proportion of children (and adults) who
    present with claims of or attraction to a transgender identity suffer from identifiable psychiatric
    co-morbidities. (See supra ¶ 57.) Regardless of whether these are in any way related to the
    child’s gender identity, it is important that these co-morbidities—if they exist—be identified and
    that appropriate psychotherapeutic help is obtained for the child. And, regardless of whether co-

 

25 See D. Shumer, N. Nokoff & N. Spack (2016), Advances in the Care of Transgender
Children & Adults, ADV. PEDIATR. (2016) at 7, DOI: 10.1016/j.yapd.2016.04.018:  “The
Endocrine Society guidelines recommend that children and adolescents with gender concerns be
seen by a mental health professional with training in child and adolescent developmental
psychology. The mental health professional should: 1) determine whether the individual fulfills
DSM criteria for gender dysphoria; 2) inform the individual with respect to possibilities and
limitations of sex reassignment and other treatments; and 3) assess for potential psychological
comorbidities.”

 

– 29 –

 

morbidities might be apparent to an MHP given an opportunity to diagnose the child or

 

adolescent before and apart from an expression of a desire for a transgender identity, most

parents are not MHPs, and from their perspective the child or adolescent’s transgender interest may come “out of the blue,” (Littman at 13), and be the first sign that they appreciate that their child should receive professional evaluation.

  1. At the very least, then, a child who exhibits or expresses an interest in a transgender identity should be evaluated for psychiatric co-morbidities. Again, parental involvement will generally be essential for this to be done, and to be done well.
  2. Parental involvement is important for effective psychotherapeutic treatment

and support of the child.

  1. Theories as to the causes of particular psychological problems, and how they can
    best be addressed once identified, continue to vary widely, but a broad consensus has agreed on
    the importance of identifying and addressing the causes of felt distress. This is accomplished first
    and foremost by a stable relationship with a professional who has substantial experience in
    psychotherapy and who is able to form caring and empathetic relationships with the child and
    parents. It is not possible to be more specific about treatment because child therapists themselves
    are so diverse in how they think about and perform parent guidance and child interventions.
    (Zucker, Debate.)
  2. Since the child’s sense of gender develops in interaction with his parents and their own gender roles and relationships, the responsible MHP will almost certainly need to delve into family and marital dynamics. (See supra ¶ 25.) An ongoing relationship between the MHP and the parents and the child is vital to help the parents, child, other family members, and the MHP to understand the issues that need to be dealt with over time by each of them.

 

 

 

 

– 30 –

 

  1. For a child to live radically different identities at home and at school, and to

conceal what he or she perceives to be his or her true identity from parents, is psychologically
unhealthy in itself, and could readily lead to additional psychological problems. Meaningful and
healthy “support” of a child struggling with gender issues must include parents. Often, parents
are more accepting and supportive of non-standard orientation or identity in their child than the
child fears they will be. Even where parents in fact have a difficult time accepting some aspect of
their child’s identity, the path to psychological health for the child will often require addressing
and resolving or reducing that gulf between parent and child, perhaps with the aid of the MHP
experienced in family dynamics. Extended secrecy and a “double life” concealed from the

parents is rarely the path to psychological health.  For this reason at least, schools should not support deceit of parents.

  1. Parental involvement is necessary to obtain informed consent.
  2. Social transition is itself an important psychotherapeutic intervention in the life of

a child, and preliminary evidence indicates that it is an intervention that is likely to have a

dramatic impact on the child’s life over the long term. The ethical MHP (and the informed and ethical educator) will not undertake such an intervention without obtaining informed consent. The complex and long-term social, medical, and mental health implications of adopting a
transgender identity—along with the complicating psychological co-morbidities that accompany transgender feelings in many individuals—make the process of obtaining informed consent
lengthy and complex under the best of circumstances. (See Section VIII.) Most children are both legally and developmentally incapable of giving informed consent to such a life-altering
intervention. And parents, of course, cannot give informed consent if the fact of their child’s wish to assume a transgender identity is concealed from them.

 

 

 

– 31 –

 

  1. All mental health professionals are aware that situations occur in which parents

act in a manner that seriously imperils the well-being of their child. This is not the general

 

expectation, and is not lightly assumed. When this is thought to be the situation, medical or

mental health professionals or educators may seek judicial intervention to remove children from the custody of their parents.  But these processes are surrounded by procedures and safeguards to protect against casual disruption of parental authority and the bond between parents and child. The school alone should not make these decisions.

  1. THE AVAILABLE DATA DOES NOT SUPPORT THE CONTENTION THAT

“AFFIRMATION” OF TRANSGENDER IDENTITY REDUCES SUICIDE OR RESULTS IN BETTER PHYSICAL OR MENTAL HEALTH OUTCOMES
GENERALLY.

  1. I am aware that organizations including The Academy of Pediatrics and Parents,
    Families and Friends of Lesbians and Gays (PFLAG)) have published statements that suggest
    that all children who express a desire for a transgender identity should be promptly supported in
    that claimed identity. This position appears to rest on the belief—which is widely promulgated
    by certain advocacy organizations—that science has already established that prompt
    “affirmance” is best for all patients, including all children, who present indicia of transgender
    identity. As I discuss later below, this belief is scientifically incorrect, and ignores both what is
    known and what is unknown.
  2. The knowledge-base concerning the causes and treatment of gender dysphoria has low scientific quality.
  3. In evaluating claims of scientific or medical knowledge, it is important to

understand that it is axiomatic in science that no knowledge is absolute, and to recognize the

 

widely-accepted hierarchy of reliability when it comes to “knowledge” about medical or

 

psychiatric phenomena and treatments. Unfortunately, in this field opinion is too often confused

 

 

– 32 –

 

with knowledge, rather than clearly locating what exactly is scientifically known. In order of

 

increasing confidence, such “knowledge” may be based upon data comprising:

  1. Expert opinion—it is perhaps surprising to educated laypersons that expert
    opinion standing alone is the lowest form of knowledge, the least likely to be proven
    correct in the future, and therefore does not garner as much respect from professionals as
    what follows.
  2. A single case or series of cases (what could be called anecdotal evidence); (Levine, Reflections, at 239.)
  3. A series of cases with a control group;

 

  1. A cohort study;
  2. A randomized double-blind clinical trial;

 

  1. A review of multiple trials;
  2. A meta-analysis of multiple trials that maximizes the number of patients
    treated despite their methodological differences to detect trends from larger data sets.
  3. Prominent voices in the field have emphasized the severe lack of scientific
    knowledge in this field. The American Academy of Child and Adolescent Psychiatry has
    recognized that “Different clinical approaches have been advocated for childhood gender

discordance……. There have been no randomized controlled trials of any treatment….. [T]he

proposed benefits of treatment to eliminate gender discordance…must be carefully weighed
against… possible deleterious effects.” (Adelson et al., Practice Parameter, at 968-69.)
Similarly, the American Psychological Association has stated, “…because no approach to

 

 

 

 

 

 

 

– 33 –

 

working with [transgender and gender nonconforming] children has been adequately, empirically

 

validated, consensus does not exist regarding best practice with pre-pubertal children.”26

  1. Critically, “there are no randomized control trials with regard to treatment of
    children with gender dysphoria.” (Zucker, Myth of Persistence, at 8.) On numerous critical
    questions relating to cause, developmental path if untreated, and the effect of alternative
    treatments, the knowledge base remains primarily at the level of the practitioner’s exposure to
    individual cases, or multiple individual cases. As a result, claims to certainty are not justifiable.
    (Levine, Reflections, at 239.)
  2. Large gaps exist in the medical community’s knowledge regarding the long-
    term effects of SRS and other gender identity disorder treatments in relation to their positive or
    negative correlation to suicidal ideation, attempts, and completion. What is known, however, is
    not encouraging.
  3. With respect to suicide, individuals with gender dysphoria are well known to

commit suicide or otherwise suffer increased mortality before and after not only social transition,
but also before and after SRS. (Levine, Reflections, at 242.) For example, in the United States,
the death rates of trans veterans are comparable to those with schizophrenia and bipolar
diagnoses—20 years earlier than expected. These crude death rates include significantly elevated
suicide rates. (Levine, Ethical Concerns, at 10.) Similarly, researchers in Sweden and Denmark
have reported on almost all individuals who underwent sex-reassignment surgery over a 30-year
period.27 The Swedish follow-up study found a suicide rate in the post-SRS population 19.1

 

 

 

26 American Psychological Association, Guidelines for Psychological Practice with
Transgender & Gender Nonconforming People (2015), AM. PSYCHOLOGIST 70(9) 832 at 842.

27 C. Dhejne et al. (2011), Long-Term Follow-Up of Transsexual Persons Undergoing

Sex Reassignment Surgery: Cohort Study in Sweden, PLOS ONE 6(2) e16885 (“Long Term”); R.

 

– 34 –

 

times greater than that of the controls; both studies demonstrated elevated mortality rates from

 

medical and psychiatric conditions. (Levine, Ethical Concerns, at 10.)

  1. Advocates of immediate and unquestioning affirmation of social transition in
    children who indicate a desire for a transgender identity sometimes assert that any other course will result in a high risk of suicide in the affected children and young people. Contrary to these assertions, no studies show that affirmation of children (or anyone else) reduces suicide, prevents suicidal ideation, or improves long-term outcomes, as compared to either a “watchful waiting” or a psychotherapeutic model of response, as I have described above.28
  2. I will also note that any discussion of suicide when considering younger children involves very long-range and very uncertain prediction. Suicide in pre-pubescent children is rare and the existing studies of gender identity issues in pre-pubescent children do not report
    significant incidents of suicide. The estimated suicide rate of trans adolescents is the same as teenagers who are in treatment for serious mental illness. What trans teenagers do demonstrate is more suicidal ideation and attempts (however serious) than other teenagers.29
  3. In sum, claims that affirmation will reduce the risk of suicide for children are not
    based on science. Such claims overlook the lack of even short-term supporting data as well as the
    lack of studies of long-term outcomes resulting from the affirmation or lack of affirmation of
    transgender identity in children. It also overlooks the other tools that the profession does have for

 

  1. Simonsen et al. (2016), Long-Term Follow-Up of Individuals Undergoing Sex Reassignment Surgery: Psychiatric Morbidity & Mortality, NORDIC J. OF PSYCHIATRY 70(4).

28 A recent article, J. Turban et al. (2020), Puberty Suppression for Transgender Youth and Risk of Suicidal Ideation, PEDIATRICS 145(2), DOI: 10.1542/peds.2019-1725, has been
described in press reports as demonstrating that administration of puberty suppressing hormones to transgender adolescents reduces suicide or suicidal ideation. The paper itself does not make that claim, nor permit that conclusion.

29 A. Perez-Brumer, J. K. Day et al. (2017), Prevalence & Correlates of Suicidal Ideation Among Transgender Youth in Cal.: Findings from a Representative, Population-Based Sample of High Sch. Students, J. AM. ACAD. CHILD ADOLESCENT PSYCHIATRY 56(9), 739 at 739.

 

– 35 –

 

addressing depression and suicidal thoughts in a patient once that risk is identified. (Levine,

 

Reflections, at 242.)

 

  1. A number of data sets have also indicated significant concerns about wider

indicators of physical and mental health, including ongoing functional limitations;30 substance
abuse, depression, and psychiatric hospitalizations;31 and increased cardiovascular disease,
cancer, asthma, and COPD.32 Worldwide estimates of HIV infection among transgendered
individuals are up to 17-fold higher than the cisgender population. (Levine, Informed Consent, at

6.)

  1. Meanwhile, no studies show that affirmation of pre-pubescent children leads to
    more positive outcomes (mental, physical, social, or romantic) by, e.g., age 25 or older than does
    “watchful waiting” or ordinary therapy. Because children’s affirmation, social transition, and the
    use of puberty blockers for transgender children are a recent phenomenon, it could hardly be
    otherwise.
  2. Thus, transition of any sort must be justified, if at all, as a life-enhancing measure, not a lifesaving measure. (Levine, Reflections, at 242.) In my opinion, this is an important fact that patients, parents, and even many MHPs fail to understand.

 

 

 

 

 

 

 

30 G. Zeluf, C. Dhejne et al. (2016), Health, Disability and Quality of Life Among Trans
People in Sweden—A Web-Based Survey, BMC PUBLIC HEALTH 16(903), DOI: 10.1186/s12889-
016-3560-5.

31 C. Dhejne, R. Van Vlerken et al. (2016), Mental Health & Gender Dysphoria: A Review of the Literature, INT’L REV. OF PSYCHIATRY  28(1) 44.

32 C. Dragon, P. Guerino, et al. (2017), Transgender Medicare Beneficiaries & Chronic Conditions: Exploring Fee-for-Service Claims Data, LGBT HEALTH 4(6) 404, DOI:

10.1089/lgbt.2016.0208.

 

– 36 –

 

VII.    KNOWN, LIKELY, OR POSSIBLE DOWNSIDE RISKS ATTENDANT ON
MOVING QUICKLY TO “AFFIRM” TRANSGENDER IDENTITY IN

CHILDREN.

  1. As I have detailed above, enabling and affirming social transition in a

prepubescent child appears to be highly likely to increase the odds that the child will in time
pursue pubertal suppression and persist in a transgender identity into adulthood. I consider the
ethical implications of this intervention in the next section. Here, I simply note that fact to
observe that the MHP (and parent) must therefore consider long term as well as short term
implications of life as a transgender individual when deciding whether to permit or encourage a
child to socially transition.

  1. The multiple studies from different nations that have documented the increased vulnerability of the adult transgender population to substance abuse, mood and anxiety disorders, suicidal ideation, and other health problems warn that assisting the child down the road to
    becoming a transgender adult is a very serious decision, and stand as a reminder that a casual assumption that transition will improve the child’s life is not justified based on numerous
    scientific snapshots of cohorts of trans adults and teenagers.
  2. The possibility that steps along this pathway, while lessening the pain of gender
    dysphoria, could lead to additional sources of crippling emotional and psychological pain, are
    too often not considered by advocates of social transition and not considered at all by the trans
    child. (Levine, Reflections, at 243.) Many and likely most educators do not have the information
    and professional experience to give these possibilities appropriate consideration, or to help a
    child do so.
  3. I detail below several classes of predictable, likely, or possible harms to the patient associated with transitioning to live as a transgender individual.

 

 

 

– 37 –

 

  1. Physical risks associated with transition
  2. Sterilization. Obviously, SRS that removes testes, ovaries, or the uterus is

inevitably sterilizing. While by no means all transgender adults elect SRS, many patients do

ultimately feel compelled to take this serious step in their effort to live fully as the opposite sex.
More immediately, practitioners recognize that the administration of cross-sex hormones, which
is often viewed as a less “radical” measure, and is now increasingly done to minors, creates at
least a risk of irreversible sterility.33 As a result, even when treating a child, the MHP, patient,
and parents must consider loss of reproductive capacity—sterilization—to be one of the major
risks of starting down the road. The risk that supporting social transition may put the child on a
pathway that leads to intentional or unintentional permanent sterilization is particularly

concerning given the disproportionate representation of minority and other vulnerable groups

among children reporting a transgender or gender-nonconforming identity. (See supra ¶ 21.)

  1. Loss of sexual response. Puberty-blockers prevent maturation of the sexual organs
    and response. Some and perhaps many transgender individuals who transitioned as children and
    thus did not go through puberty consistent with their sex face significantly diminished sexual
    response as they enter adulthood, and are unable ever to experience orgasm. To my knowledge,
    data quantifying this impact has not been published. In the case of males, the cross-sex
    administration of estrogen limits penile genital function. Much has been written about the
    negative psychological and relational consequences of anorgasmia among non-transgender
    individuals that is ultimately applicable to the transgendered. (Levine, Informed Consent, at 6.)

 

 

 

33 See C. Guss et al., TGN Adolescent Care at 4 (“a side effect [of cross-sex hormones]

may be infertility”) and 5 (“cross-sex hormones . . . may have irreversible effects”); Tishelman et al., Serving TG Youth at 8 (Cross-sex hormones are “irreversible interventions” with “significant ramifications for fertility”).

 

– 38 –

 

  1. Other effects of hormone administration. While it is commonly said that the

effects of puberty blockers are reversible after cessation, in fact controlled studies have not been
done of how completely this is true. However, it is well known that many effects of cross-sex
hormones cannot be reversed should the patient later regret his transition. After puberty, the
individual who wishes to live as the opposite sex will in most cases have to take cross-sex
hormones for life.

  1. The long-term health risks of this major alteration of hormonal levels have not yet
    been quantified in terms of exact risk.34 However, a recent study found greatly elevated levels of
    strokes and other acute cardiovascular events among male-to-female transgender individuals
    taking estrogen. Those authors concluded, “it is critical to keep in mind that the risk for these
    cardiovascular events in this population must be weighed against the benefits of hormone
    treatment.”35 Another group of authors similarly noted that administration of cross-sex hormones
    creates “an additional risk of thromboembolic events”—which is to say blood clots (Guss et al.,
    TGN Adolescent Care at 5), which are associated with strokes, heart attack, and lung and liver
    failure. Clinicians must distinguish the apparent short-term safety of hormones from likely or
    possible long-term consequences, and help the patient or parents understand these implications
    as well. The young patient may feel, “I don’t care if I die young, just as long I get to live as a
    woman.” The mature adult may take a different view.

 

 

 

 

 

 

34 See Tishelman et al., Serving TG Youth at 6-7 (Long-term effect of cross-sex hormones “is an area where we currently have little research to guide us”).

35 D. Getahun et al. (2018), Cross-Sex Hormones and Acute Cardiovascular Events in

Transgender Persons: A Cohort Study, ANNALS OF INTERNAL MEDICINE at 8, DOI:10.7326/M17-
2785.

 

– 39 –

 

  1. Health risks inherent in complex surgery. Complications of surgery exist for each

procedure,36 and complications in surgery affecting the reproductive organs and urinary tract can have significant anatomical and functional complications for the patient’s quality of life.
107. Disease and mortality generally. The MHP, the patient, and in the case of a child the parent, must also be aware of the wide sweep of strongly negative health outcomes among transgender individuals, as I have detailed above.

  1. Social risks associated with transition
  2. Family and friendship relationships. Gender transition routinely leads to isolation

from at least a significant portion of one’s family in adulthood. In the case of a juvenile

transition, this will be less dramatic while the child is young, but commonly increases over time as siblings who marry and have children of their own do not wish the transgender individual to be in contact with those children. By adulthood, the friendships of transgender individuals tend to be confined to other transgender individuals (often “virtual” friends known only online) and the generally limited set of others who are comfortable interacting with transgender individuals. (Levine, Ethical Concerns, at 5.)

  1. Long term psychological and social impact of sterility. The life-long negative

emotional impact of infertility on both men and women has been well studied.  While this impact
has not been studied specifically within the transgender population, the opportunity to be a
parent is likely a human, emotional need, and so should be considered an important risk factor
when considering gender transition for any patient. However, it is particularly difficult for
parents of a young child to seriously contemplate that child’s potential as a future parent and

 

 

36 Levine, Informed Consent, at 5 (citing T. van de Grift, G. Pigot et al. (2017), A

Longitudinal Study of Motivations Before & Psychosexual Outcomes After Genital GenderConfirming Surgery in Transmen, J. SEXUAL MEDICINE 14(12) 1621.).

 

– 40 –

 

grandparent. This makes it all the more critical that the MHP spend substantial and repeated time

 

with parents to help them see the implications of what they are considering.

  1. Sexual-romantic risks associated with transition. After adolescence, transgender
    individuals find the pool of individuals willing to develop a romantic and intimate relationship
    with them to be greatly diminished. When a trans person who passes well reveals his or her natal
    sex, many potential cisgender mates lose interest. When a trans person does not pass well, he
    discovers that the pool of those interested consists largely of individuals looking for exotic
    sexual experiences rather than genuinely loving relationships. (Levine, Ethical Concerns, at 5,

13.) Nor is the problem all on the other side; transgender individuals commonly become strongly narcissistic, unable to give the level of attention to the needs of another that is necessary to
sustain a loving relationship.37

  1. Social risks associated with delayed puberty. The social and psychological impact
    of remaining puerile for, e.g., three years while one’s peers are undergoing puberty, and of
    undergoing puberty at a substantially older age, have not been systematically studied, although
    clinical mental health professionals often hear of distress and social awkwardness in those who
    naturally have a delayed onset of puberty. In my opinion, individuals in whom puberty is delayed
    multiple years are likely to suffer at least subtle negative psychosocial and self-confidence
    effects as they stand on the sidelines while their peers are developing the social relationships
    (and attendant painful social learning experiences) that come with adolescence. (Levine,
    Informed Consent, at 9.)

 

 

 

 

 

37 S. Levine, Barriers to Loving: A Clinician’s Perspective, at 40 (Routledge, New York
2013).

 

– 41 –

 

  1. Mental health costs or risks
  2. One would expect the negative physical and social impacts reviewed above to

adversely affect the mental health of individuals who have transitioned. In addition, adult

transitioned individuals find that living as the other (or, in a manner that is consistent with the stereotypes of the other as the individual perceives them) is a continual challenge and stressor, and many find that they continue to struggle with a sense of inauthenticity in their transgender identity. (Levine, Informed Consent, at 9.)

  1. In addition, individuals often pin excessive hope in transition, believing that transition will solve what are in fact ordinary social stresses associated with maturation, or mental health co-morbidities. Thus, transition can result in deflection from mastering personal challenges at the appropriate time, or addressing conditions that require treatment.
  2. Whatever the reason, transgender individuals including transgender youth

certainly experience greatly increased rates of mental health problems. I have detailed this above
with respect to adults living under a transgender identity. Indeed, Swedish researchers in a long-
term study (up to 30 years since SRS, with a median time since SRS of > 10 years) concluded
that individuals who have SRS should have postoperative lifelong psychiatric care.  (Dhejne,
Long Term, at 6-7.) With respect to youths a cohort study found that transgender youth had an
elevated risk of depression (50.6% vs. 20.6%) and anxiety (26.7% vs. 10.0%); a higher risk of
suicidal ideation (31.1% vs. 11.1%), suicide attempts (17.2% vs. 6.1%), and self-harm without
lethal intent (16.7% vs. 4.4%) relative to the matched controls; and a significantly greater

 

 

 

 

 

 

 

 

 

– 42 –

 

proportion of transgender youth accessed inpatient mental health care (22.8% vs. 11.1%) and

 

outpatient mental health care (45.6% vs. 16.1%) services.38

 

  1. Regret following transition is not an infrequent phenomenon.
  2. The large numbers of children and young adults who have desisted as documented

in both group and case studies each represent “regret” over the initial choice in some sense.
116. The phenomenon of desistance or regret experienced later than adolescence or young adulthood, or among older transgender individuals, has to my knowledge not been quantified or well studied. However, it is a real phenomenon. I myself have worked with multiple individuals who have abandoned trans female identity after living in that identity for years, and who would describe their experiences as “regret.”

  1. I have seen several Massachusetts inmates and trans individuals in the community
    abandon their [trans] female identity after several years. (Levine, Reflections, at 239.) In the
    gender clinic which I founded in 1974 and to this day, in a different location, continue to co-
    direct, we have seen many instances of individuals who claimed a transgender identity for a time,
    but ultimately changed their minds and reclaimed the gender identity congruent with their sex.
  2. More dramatically, a surgical group prominently active in the SRS field has

published a report on a series of seven male-to-female patients requesting surgery to transform
their surgically constructed female genitalia back to their original male form.39
119. I noted above an increasingly visible online community of young women who have desisted after claiming a male gender identity at some point during their teen years. (See supra ¶ 62.) Given the rapid increase in the number of girls presenting to gender clinics within

38 S. Reisner et al. (2015), Mental Health of Transgender Youth in Care at an Adolescent Urban Community Health Center: A Matched Retrospective Cohort Study, J. OF ADOLESCENT HEALTH 56(3) at 6, DOI:10.1016/j.jadohealth.2014.10.264; see also supra ¶ 21.

39 Djordjevic et al. (2016), Reversal Surgery in Regretful Male-to-Female Transsexuals
After Sex Reassignment Surgery, J. Sex Med. 13(6) 1000, DOI: 10.1016/j.jsxm.2016.02.173.

 

– 43 –

 

the last few years, the phenomena of regret and desistance by young women deserves careful

 

attention and study by MHPs.

 

  1. Thus, one cannot assert with any degree of certainty that once a transgendered

person, always a transgendered person, whether referring to a child, adolescent, or adult, male or
female.

VIII.   MEDICAL ETHICS & INFORMED CONSENT

  1. The obligation of the mental health professional to enable and obtain

informed consent

  1. I have reviewed above the knowledge and experience that, in my view, a mental health professional should have before undertaking the responsibility to counsel or treat a child who is experiencing gender dysphoria or transgender identification. The MHP who undertakes this type of responsibility must also be guided by the ethical principles that apply to all health
    care professionals. One of the oldest and most fundamental principles guiding medical and
    psychological care—part of the Hippocratic Oath—is that the physician must “first, do no harm.” This states an ethical responsibility that cannot be delegated to the patient. Physicians themselves must weigh the risks of treatment against the harm of not treating. If the risks of treatment
    outweigh the benefits, ethics prohibit the treatment.
  2. A distinct ethical responsibility of physicians, when a significant risk exists of

adverse consequences to any procedure or therapy, is to ensure that the patient understands and is legally able to consent to the treatment, and does consent. To achieve informed consent, the
MHP must do at least the following:

  1. The MHP must reasonably inform himself regarding the particular situation of his patient;

 

 

 

 

– 44 –

 

  1. The MHP must reasonably inform himself concerning the state of knowledge

 

concerning relevant methodologies and outcomes;

  1. The MHP must honestly inform the patient concerning not only the benefits of treatment, but also the risks and downsides of treatment, and alternative treatments.
  2. The MHP must conclude that the patient (or the decision maker, such as

parent or healthcare power of attorney) has comprehended what he or she has been told and possesses a cognitive capacity to make a decision based on an adequate
understanding of his or her unique life circumstances.

  1. Perfunctory “consent” is inadequate to fulfill the professional’s ethical obligation
    to obtain informed consent. At the very least, a patient (or parent) considering the life-altering
    choice of transition should be helped or indeed required by their clinicians to grapple with four
    relevant questions:
  2. “What benefits do you expect that the consolidation of this identity, gender transition, hormones, or surgery will provide?
  3. “What do you understand of the social, educational, vocational, and
    psychological risks of this identity consolidation and gender role transition?
  4. “What do you understand about the common and rare, short- and long-term medical and health risks of hormone and surgical interventions?
  5. “What have you considered the nature of your life will be in 10 to 20 years?” (Levine, Informed Consent, at 3.)
  6. The answers of the patient will enable the professional to make a judgment about
    how realistic he or she is being. For example, the biological boy who envisions himself as a
    happy, attractive, socially accepted 21-year-old girl in future college years has probably not been

 

 

 

– 45 –

 

adequately informed of—or has mentally blocked—hard data concerning the mental health and

social wellbeing of the transgender population in their 20s, and is failing to consider the material risk that he, as a transgender individual, will not be perceived as attractive to either sex, and the impact that this may have on his future well-being.

  1. Most commonly, meaningful engagement with difficult and painful questions such as those above requires a process that will consist of multiple discussions in a
    psychotherapeutic or counseling context, not merely “disclosure” of facts. In my experience, a too-rapid or too-eager attachment to some outcome is a red warning flag that the patient is not able to tolerate knowledge of the risks and alternative approaches.
  2. In my experience, in the area of transgender therapy, rather than the type of information and engagement that I have described, even mental health professionals too often encourage or permit decisions based on a great deal of patient and professional blind optimism about the future. (Levine, Ethical Concerns, at 3-4.)
  3. In my judgment, few if any educators who are not also trained mental health

professionals will have the knowledge and the training needed to engage in the probing process
of informed consent that I have described above, and few will even be aware of the full
implications of this ethical principle. They may also be unaware of—or even reject—the well-
recognized developmental, ethical, and legal limits on the ability of children to grant consent to
serious medical or psychotherapeutic interventions. When the clinical experience and areas of
competence of even PhD school psychologists are considered, it is usually apparent that their
training and professional experiences to date  do not equip them to guide parents and children
through the uncertainties and ethical dilemmas inherent in children and adolescents who are
struggling with gender identity issues or experiencing a sense of transgender identity.

 

 

 

– 46 –

 

  1. The interests of the patient, as well as necessary disclosures and consent,

must be considered from a life course perspective.

  1. The psychiatrist or psychologist treating a child must have in view not merely (or not even primarily) making the child “happy” now, but making him or her as healthy and happy as possible across the entire trajectory of life, to the extent that is predictable. Certainly, avoiding suicide is one important aspect of a “life course” analysis, and recognizes that “today” is not the only goal. But as I have reviewed above, there is much more across the future decades of the patient’s life that also needs to be taken into account.
  2. Further, I do not believe that a patient can meaningfully be said to know what will
    make him “happy” over the long term, prior to receiving, understanding, and usually discussing
    the type of information that I have described above in connection with informed consent. With
    respect to children who are not equipped to understand, evaluate, and feel the life implications of
    such information, it is doubtful that there is any meaningful way in which they can be said to
    “know” what will make them happy over the long term. It is for similar reasons that parents
    ordinarily make a great many decisions, both large and small, for their young children.
  3. Of particular relevance to the life course perspective, when gender-typical men
    and women undergo elective sterilization, there is a distinct likelihood of eventual regret. It has
    been documented that the younger the age of sterilization, the greater incidence of regret and
    increased numbers of requests to reverse the sterilized state. Thus, the medical profession and the
    courts are quite clear about sterilization: the adult patient must be cognitively able to prudently
    consider the future consequences in terms of his or her life circumstances. In minors sterilization
    should be done only to save a life.40 This observation has implications for facilitating or even

 

40 See S. D. Hillis et al. (1999), Poststerilization Regret: Findings from the United States Collaborative Review of Sterilization, OBSTETRICS. & GYN. 93(6) 889; A. Burgart et al. (2017), Ethical Controversy About Hysterectomy for a Minor, PEDIATRICS 139(6),

 

– 47 –

 

permitting children or adolescents to embark on a path of social transition that within a few years

 

may psychologically steer that individual towards sterilizing chemical or surgical procedures.

 

  1. Special concerns and ethical rules governing experimentation on patients
  2. When psychiatric or medical research is done on subjects the informed consent

process is far more rigorous than in ordinary medical and psychiatric procedures. For example, in a recent study of an agent to assist women who are distressed by their lack of sexual desire that I was a part of, the Informed Consent document was 19 pages long.

  1. The absence of long-term studies in the arena of childhood gender dysphoria or
    the more recently documented phenomenon of “rapid onset gender dysphoria” among
    adolescents means that therapeutic responses to these conditions are still at a primitive stage of
    development, and must be considered to be experimental, rendering adequately informed consent
    all the more essential, and all the more difficult to obtain. Claims that a civil right is at stake do
    not change the fact that what is proposed is a social and medical experiment. (Levine,
    Reflections, at 241.)
  2. Ethical principles do not permit using patients as “change agents.”
  3. Some advocates assert that various mental health pathologies commonly observed

in patients who have transitioned result from societal prejudice, and would not occur if society

were different. This is, of course, a hypothesis rather than demonstrated fact, and it is in any case
ethically irrelevant to the treatment of an individual patient. If a therapy or life course under
consideration for a child will predictably lead to social and family isolation and unemployment

 

DOI:10.1542/peds.2016-3992; K. Curtis et al. (2006), Regret Following Female Sterilization at a Young Age: A Systematic Review, CONTRACEPTION 73, 205,

DOI:10.1016/j.contraception.2005.08.006; A. Tamar-Mattis (2009), Exploring Gray Areas in the Law About DSD and Sterilization, ENDOCRINE TODAY, October ed.,

https://www.healio.com/endocrinology/reproduction-androgen-disorders/news/print/endocrine-
today/%7Bc6029f85-28ac-43f4-9e7e-0fc897f6313f%7D/exploring-gray-areas-in-the-law-about-
dsd-and-sterilization.

 

– 48 –

 

later in life given society as it exists, for a MHP or other advisor to recommend or encourage that

 

path nonetheless seems to lose sight of the welfare of the patient. To do so appears to be

intentionally using the child as not merely an experiment, but as a change-agent—potentially at great personal cost—rather than seeking the lifetime best interests of that child. (Levine, Ethical Concerns, at 9.)

  1. The inability of children to understand major life issues and risks

complicates informed consent.

  1. Obviously, most children cannot give legally valid consent to a medical

procedure.41 This is not a mere legal technicality. Instead, it is a legal reflection of a reality of human development that is highly relevant to the ethical requirement of informed consent quite apart from law. The argument that the child is consenting to the transition by his happiness ignores the fact just described.

  1. Each age group poses different questions about risk comprehension. (Levine,

Informed Consent, at 3.) While the older patient is perhaps more likely to be formally mental ill and delusional, the young child is chronically unable to comprehend large and complex issues such as the meaning of biological sex, the meaning of gender, and the risks and life implications attendant on social, hormonal, and ultimately surgical transition.

  1. In my experience, when clinicians actually attempt to understand patients’
    motives for the repudiation of their natal gender, the developmental lack of sophistication
    underlying their reasons can become apparent. What must a 12-year-old, for example,
    understand about masculinity and femininity that enables the conviction that “I can never be
    happy in my body?” (Levine, Ethical Concerns, at 8.) Obviously, this unavoidable gap in
    comprehension and ability to foresee must be still larger for younger children.

41 I recognize that in some States or under some circumstances “mature minors” may be legally empowered to grant consent to certain medical procedures.

 

– 49 –

 

  1. Similarly, one cannot expect a 17-year-old to grasp the complexity of married life

with children when 38. One cannot expect a ten-year-old to understand the emotional growth that
comes from a first long term love relationship including sexual behavior. One cannot expect a
six-year-old to comprehend the changes in his psyche that may come about as the resull of
puberty.

  1. For this reason, it is my opinion that asking a child whether he or she wishes to transition to living as the opposite sex, or giving large weight to the child’s expressed wishes, by no means satisfies the M-IP’s ethical obligation to obtain informed consent before assisting that child to transition to living as the opposite sex.
  2. In light of the profound uncertainties in the field, and Lhe many highly predictable
    or probable lifetime costs to the child if he or she persists in a transgender identity into
    adulthood, in my opinion it is not consistent with principles of medical ethics for physicians or
    other MHPs to suggest that parents should not or have no right to explore possible therapeutic
    options to assist their cbjld to achieve comfort with the gender corresponding to his or her sex.
    The use of the label “reparative therapy” by some advocates lo lump all such possible therapies
    together and disparage them does not change this equation. (Levine, Informed Consent, at 7.)

Dated: February/ P , 2020.

Jl!if

Stephen B. Levine

 

Subscribed and sworn to before me this /0″/'(jay of Fe

 

 

 

 

 

 

 

ViCTOl  V.  •·  ::1 ..o. Ailome-y

NOTAfl)  P’..’ LIC – $TATE OF C!·i!Q.
My cammi ..ic.,u h.>s .10 “:- 11 ,tlon d t..,_
dioA f…7.l·.
; R.. C.

-50 –

 

Stephen B. Levine, M.D.                                                                                         Curriculum Vita

 

Brief Introduction

Dr. Levine is Clinical Professor of Psychiatry at Case Western Reserve University School of

Medicine.  He is the solo author of four books, Sex Is Not Simple in 1989 (translated to German
in 1992 and reissued in English in 1997 as Solving Common Sexual Problems); Sexual Life: A
clinician’s guide in 1992; Sexuality in Midlife in 1998 and Demystifying Love: Plain talk for the
mental health professional in 2006; Barriers to Loving: A clinician’s perspective in October
2013. He is the Senior Editor of the first (2003), second (2010) and third (2016) editions of the
Handbook of Clinical Sexuality for Mental Health Professionals. Psychotherapeutic Approaches
to Sexual Problems: An Essential Guide For Mental Health Professionals will be published in the
fall 2019. He has been teaching, providing clinical care, and writing since 1973 and has
generated original research, invited papers, commentaries, chapters, and book reviews. He has
served as a journal manuscript and book prospectus reviewer for many years. He was co-director
of the Center for Marital and Sexual Health/ Levine, Risen & Associates, Inc. in Beachwood,
Ohio from 1992-2017. He and two colleagues received a lifetime achievement Masters and
Johnson’s Award from the Society for Sex Therapy and Research in March 2005.

Personal Information

Date of birth 1/14/42

Medical license no. Ohio 35-03-0234-L

Board Certification 6/76 American Board of Neurology and Psychiatry

Education

1963 BA Washington and Jefferson College

1967 MD Case Western Reserve University School of Medicine

1967-68 internship in Internal Medicine University Hospitals of Cleveland

1968-70 Research associate, National Institute of Arthritis and Metabolic Diseases,

Epidemiology Field Studies Unit, Phoenix, Arizona, United States Public Health Service 1970-73 Psychiatric Residency, University Hospitals of Cleveland

1974-77 Robert Wood Johnson Foundation Clinical Scholar

Appointments at Case Western Reserve University School of Medicine

1973 – Assistant Professor of Psychiatry

1979 – Associate Professor

1982 – Tenure

1985 – Full Professor

1993 – Clinical Professor

 

Page 1 of 22

 

Honors

Summa Cum Laude, Washington & Jefferson

Teaching Excellence Award – 1990 and 2010 (residency program) Visiting Professorships:

   Stanford University-Pfizer Professorship program (3 days) – 1995    St. Elizabeth’s Hospital, Washington, DC – 1998

   St. Elizabeth’s Hospital, Washington, DC – 2002

Named to America’s Top Doctors consecutively since 2001

Invitations to present various Grand Rounds at Departments of Psychiatry and Continuing Education Lectures and Workshops

Masters and Johnson Lifetime Achievement Award from the Society of Sex Therapy and Research, April 2005 along with Candace Risen and Stanley Althof

2006 SSTAR Book Award for The Handbook of Clinical Sexuality for Mental Health Professionals:  Exceptional Merit

2018 – Albert Marquis Lifetime Achievement Award from Marquis Who’s Who. (exceling in one’s field for at least twenty years)

Professional Societies

1971 – American Psychiatric Association; fellow

2005 – American Psychiatric Association – Distinguished Life Fellow 1973 – Cleveland Psychiatric Society

1973 – Cleveland Medical Library Association

  1985 – Life Fellow

  2003 – Distinguished Life Fellow

1974 – Society for Sex Therapy and Research

  1987-89 – President

1983 – International Academy of Sex Research

1983 – Harry Benjamin International Gender Dysphoria Association
 1997-98 – Chairman, Standards of Care Committee
1994-99 – Society for Scientific Study of Sex

Community Boards

1999-2002 – Case Western Reserve University Medical Alumni Association 1996-2001 – Bellefaire Jewish Children’s Bureau

 

Page 2 of 22

 

1999-2001 – Physicians’ Advisory Committee, The Gathering Place (cancer rehabilitation)

Editorial Boards

1978-80 Book Review Editor Journal Sex and Marital Therapy Manuscript Reviewer for:

  Archives of Sexual Behavior

  Annals of Internal Medicine

  British Journal of Obstetrics and Gynecology

  JAMA

  Diabetes Care

  American Journal of Psychiatry

  Maturitas

  Psychosomatic Medicine

  Sexuality and Disability

  Journal of Nervous and Mental Diseases

  Journal of Neuropsychiatry and Clinical Neurosciences

  Neurology

  Journal Sex and Marital Therapy

  Journal Sex Education and Therapy

  Social Behavior and Personality: an international journal (New Zealand)

  International Journal of Psychoanalysis

  International Journal of Transgenderism

  Journal of Urology

  Journal of Sexual Medicine

  Current Psychiatry

  International Journal of Impotence Research

  Postgraduate medical journal

  Academic Psychiatry

Prospectus Reviewer for:
   Guilford

   Oxford University Press

 

Page 3 of 22

 

   Brunner/Routledge

   Routledge

Administrative Responsibilities

Co-director, Center for Marital and Sexual Health/ Levine, Risen & Associates, Inc. until June 30, 2017

Principal Investigator of approximately 70 separate studies involving pharmacological interventions for sexual dysfunction since 1989.

Co-leader of case conferences at DELRLLC.com

Recent Expert Witness Appearances

US District Court, Judge Mark L.Wolf’s witness in Michelle Kosilek vs. Massachusetts Dept of Corrections et al. case (transsexual issue) in Boston 2007

Deposition in the Battista vs. Massachusetts Dept of Corrections case (transsexual issue) in Cleveland October 2009

Witness for Massachusetts Dept. of Corrections in their defense of a lawsuit brought by
prisoner Katheena Soneeya. March 22, 2011 Deposition in Boston and October 2018 in
Cleveland

Witness for State of Florida vs. Reyne Keohane July 2017

Expert testimony by deposition and at trial in In the Interests of the Younger Children, Dallas, TX, 2019.

Consultancy

Massachusetts Department of Corrections – evaluation of 12 transsexual prisoners and the
development of a Gender Identity Disorders Program for the state prison system.  Monthly
consultation with the GID treatment team since February 2009 and the GID policy committee
since February 2010

California Department of Corrections and Rehabilitation; 2012-2015; education, inmate evaluation, commentary on inmate circumstances, suggestions on future policies

Virginia Department of Corrections – evaluation of an inmate

New Jersey Department of Corrections – evaluation of an inmate Idaho Department of Corrections – workshop 2016

Grant Support/Research Studies

TAP – studies of Apomorphine sublingual in treatment of erectile dysfunction Pfizer – Sertraline for premature ejaculation

Pfizer – Viagra and depression; Viagra and female sexual dysfunction; Viagra as a treatment for SSRI-induced erectile dysfunction

 

 

Page 4 of 22

 

NIH – Systemic lupus erythematosis and sexuality in women

Sihler Mental Health Foundation

   Program for Professionals

   Setting up of Center for Marital and Sexual Health    Clomipramine and Premature ejaculation

   Follow-up study of clergy accused of sexual impropriety
   Establishment of services for women with breast cancer  Alza – controlled study of a novel SSRI for rapid ejaculation Pfizer – Viagra and self-esteem

Pfizer – double-blind placebo control studies of a compound for premature ejaculation

Johnson & Johnson – controlled studies of Dapoxetine for rapid ejaculation

Proctor and Gamble – multiple studies to test testosterone patch for post menopausal sexual dysfunction for women on and off estrogen replacement

Lilly-Icos – study of Cialis for erectile dysfunction

VIVUS – study for premenopausal women with FSAD

Palatin Technologies – studies of bremelanotide in female sexual dysfunction—first intranasal then subcutaneous administration

Medtap – interview validation questionnaire studies

HRA – quantitative debriefing study for Female partners of men with premature ejaculation, Validation of a New Distress Measure for FSD,

Boehringer-Ingelheim – double blind and open label studies of a prosexual agent for hypoactive female sexual desire disorder

Biosante – studies of testosterone gel administration for post menopausal women with HSDD J&J – a single-blind, multi-center, in home use study to evaluate sexual enhancement effects of a product in females.

UBC – Content validity study of an electronic FSEP-R and FSDS-DAO and usability of study PRO measures in premenopausal women with FSAD, HSDD or Mixed FSAD/HSDD

National registry trial for women with HSDD

Endoceutics – two studies of DHEA for vaginal atrophy and dryness in post menopausal
women

Palatin – study of SQ Bremelanotide for HSDD and FSAD

Trimel – a double-blind, placebo controlled study for women with acquired female orgasmic
disorder.

 

 

Page 5 of 22

 

S1 Biopharma – a phase 1-B non-blinded study of safety, tolerability and efficacy of Lorexys in premenopausal women with HSDD

HRA – qualitative and cognitive interview study for men experiencing PE

Publications

  1. A) Books

1)    Pariser SR, Levine SB, McDowell M (eds.), Clinical Sexuality, Marcel Dekker, New

York, 1985

2)    Sex Is Not Simple, Ohio Psychological Publishing Company, 1988; Reissued in

paperback as: Solving Common Sexual Problems: Toward a Problem Free Sexual Life, Jason Aronson, Livingston, NJ. 1997

3)    Sexual Life: A Clinician’s Guide. Plenum Publishing Corporation. New York, 1992

4)    Sexuality in Midlife. Plenum Publishing Corporation. New York, 1998

5)    Editor. Clinical Sexuality. Psychiatric Clinics of North America, March, 1995.

6)    Editor, (Candace Risen and Stanley Althof, associate editors) Handbook of Clinical

Sexuality for Mental Health Professionals. Routledge, New York, 2003

(a) 2006 SSTAR Book Award: Exceptional Merit

7)    Demystifying Love: Plain Talk For The Mental Health Professional. Routledge, New

York, 2006

8)    Senior editor, (Candace B. Risen and Stanley E. Althof, Associate editors),

Handbook of Clinical Sexuality for Mental Health Professionals. 2nd edition

Routledge, New York, 2010.  See review by Pega Ren, JSex&Marital Therapy

9)    Barriers to Loving: A Clinician’s Perspective.  Routledge, New York, 2014.

10) Senior editor Candace B. Risen and Stanley E. Althof, Associate editors), Handbook

of Clinical Sexuality for Mental Health Professionals. 3rd edition Routledge, New York, 2016

  1. B) Research and Invited Papers

(When his name is not listed in a citation, Dr. Levine is either the solo or the senior author)

1)   Sampliner R. Parotid enlargement in Pima Indians. Annals of Internal Medicine
1970; 73:571-73

2)   Confrontation and residency activism: A technique for assisting residency change:
World Journal of Psychosynthesis 1974; 6: 23-26

3)   Activism and confrontation: A technique to spur reform.  Resident and Intern
Consultant 173; 2

4)   Medicine and Sexuality. Case Western Reserve Medical Alumni Bulletin 1974:37:9-

 

 

Page 6 of 22

 

5)    Some thoughts on the pathogenesis of premature ejaculation. J. Sex & Marital

Therapy 1975; 1:326-334

6)    Marital Sexual Dysfunction: Introductory Concepts. Annals of Internal Medicine

1976;84:448-453

7)    Marital Sexual Dysfunction: Ejaculation Disturbances 1976; 84:575-579

8)    Yost MA: Frequency of female sexual dysfunction in a gynecology clinic: An

epidemiological approach. Archives of Sexual Behavior 1976;5:229-238

9)    Engel IM, Resnick PJ, Levine SB: Use of programmed patients and videotape in

teaching medical students to take a sexual history. Journal of Medical Education 1976;51:425-427

10) Marital Sexual Dysfunction: Erectile dysfunction. Annals of Internal Medicine

1976;85:342-350

11) Articles in Medical Aspects of Human Sexuality

(a)   Treating the single impotent male. 1976; 10:123, 137

(b)   Do men enjoy being caressed during foreplay as much as women do? 1977; 11:9

(c)   Do men like women to be sexually assertive? 1977;11:44

(d)   Absence of sexual desire in women: Do some women never experience sexual

desire? Is this possibility genetically determined? 1977; 11:31

(e)   Barriers to the attainment of ejaculatory control. 1979; 13:32-56.

(f)   Commentary on sexual revenge.1979;13:19-21

(g)  Prosthesis for psychogenic impotence? 1979;13:7

(h)  Habits that infuriate mates. 1980;14:8-19

(i)   Greenberger-Englander, Levine SB. Is an enema an erotic equivalent?1981;

15:116

(j)   Ford AB, Levine SB. Sexual Behavior and the Chronically Ill Patients. 1982;

16:138-150

(k)   Preoccupation with wife’s sexual behavior in previous marriage 1982; 16:172

(l)   Co-existing organic and psychological impotence. 1985;19:187-8

(m) Althof SE, Turner LA, Kursh ED, Bodner D, Resnick MI, Risen CB. Benefits
and Problems with Intracavernosal injections for the treatment of impotence.

1989;23(4):38-40

12) Male Sexual Problems. Resident and Staff Physician 1981:2:90-5

13) Female Sexual Problems. Resident and Staff Physician 1981:3:79-92

14) How can I determine whether a recent depression in a 40 year old married man is

due to organic loss of erectile function or whether the depression is the source of the

 

Page 7 of 22

 

dysfunction? Sexual Medicine Today 1977;1:13

15) Corradi RB, Resnick PJ Levine SB, Gold F. For chronic psychologic impotence: sex

therapy or psychotherapy? I & II Roche Reports; 1977

16) Marital Sexual Dysfunction: Female dysfunctions 1977; 86:588-597

17) Current problems in the diagnosis and treatment of psychogenic impotence. Journal

of Sex & Marital Therapy 1977; 3:177-186

18) Resnick PJ, Engel IM. Sexuality curriculum for gynecology residents. Journal of

Medical Education 1978; 53:510-15

19) Agle DP. Effectiveness of sex therapy for chronic secondary psychological

impotence Journal of Sex & Marital Therapy 1978; 4:235-258

20) DePalma RG, Levine SB, Feldman S. Preservation of erectile function after

aortoiliac reconstruction. Archives of Surgery 1978; 113-958-962

21) Conceptual suggestions for outcome research in sex therapy Journal of Sex &

Marital Therapy 1981; 6:102-108

22) Lothstein LM.  Transsexualism or the gender dysphoria syndrome. Journal of Sex &

Marital Therapy 1982; 7:85-113

23) Lothstein LM, Levine SB. Expressive psychotherapy with gender dysphoria patients

Archives General Psychiatry 1981; 38:924-929

24) Stern RG Sexual function in cystic fibrosis. Chest 1982; 81:422-8

25) Shumaker R. Increasingly Ruth: Towards understanding sex reassignment surgery

Archives of Sexual Behavior 1983; 12:247-61

26) Psychiatric diagnosis of patients requesting sex reassignment surgery. Journal of Sex

& Marital Therapy 1980; 6:164-173

27) Problem solving in sexual medicine I. British Journal of Sexual Medicine 1982;

9:21-28

28) A modern perspective on nymphomania. Journal of Sex & Marital Therapy 1982;

8:316-324

29) Nymphomania. Female Patient 1982;7:47-54

30) Commentary on Beverly Mead’s article: When your patient fears impotence. Patient

Care 1982; 16:135-9

31) Relation of sexual problems to sexual enlightenment. Physician and Patient 1983

2:62

32) Clinical overview of impotence. Physician and Patient 1983; 8:52-55.
33) An analytical approach to problem-solving in sexual medicine: a clinical

introduction to the psychological sexual dysfunctions. II. British Journal of Sexual
Medicine

 

Page 8 of 22

 

34) Coffman CB, Levine SB, Althof SE, Stern RG Sexual Adaptation among single

young adults with cystic fibrosis. Chest 1984; 86:412-418

35) Althof SE, Coffman CB, Levine SB. The effects of coronary bypass in female

sexual, psychological, and vocational adaptation. Journal of Sex & Marital Therapy 1984; 10:176-184

36) Letter to the editor: Follow-up on Increasingly Ruth. Archives of Sexual Behavior

1984; 13:287-9

37) Essay on the nature of sexual desire Journal of Sex & Marital Therapy 1984; 10:83-

96

38) Introduction to the sexual consequences of hemophilia. Scandanavian Journal of

Haemology 1984; 33:(supplement 40).75-

39) Agle DP, Heine P. Hemophila and Acquired Immune Deficiency Syndrome:

Intimacy and Sexual Behavior. National Hemophilia Foundation; July, 1985

40) Turner LA, Althof SE, Levine SB, Bodner DR, Kursh ED, Resnick MI. External

vacuum devices in the treatment of erectile dysfunction: a one-year study of sexual and psychosocial impact. Journal of Sex & Marital Therapy

41) Schein M, Zyzanski SJ, Levine SB, Medalie JH, Dickman RL, Alemagno SA. The

frequency of sexual problems among family practice patients. Family Practice Research Journal 1988; 7:122-134

42) More on the nature of sexual desire. Journal of Sex & Marital Therapy 1987; 13:35-

44

43) Waltz G, Risen CB, Levine SB. Antiandrogen treatment of male sex offenders.

Health Matrix 1987; V.51-55.

44) Lets talk about sex. National Hemophilia Foundation January, 1988

45) Sexuality, Intimacy, and Hemophilia: questions and answers . National Hemophilia

Foundation January, 1988

46) Prevalence of sexual problems. Journal Clinical Practice in Sexuality 1988;4:14-16. 47) Kursh E, Bodner D, Resnick MI, Althof SE, Turner L, Risen CB, Levine SB.

Injection Therapy for Impotence. Urologic Clinics of North America 1988; 15(4):625-630

48) Bradley SJ, Blanchard R, Coates S, Green R, Levine S, Meyer-Bahlburg H, Pauly I,

Zucker KJ. Interim report of the DSM-IV Subcommittee for Gender Identity Disorders. Archives of Sexual Behavior 1991;;20(4):333-43.

49) Sexual passion in mid-life. Journal of Clinical Practice in Sexuality 1991 6(8):13-19

50) Althof SE, Turner LA, Levine SB, Risen CB, Bodner DR, Resnick MI.

Intracavernosal injections in the treatment of impotence: A prospective study of sexual, psychological, and marital functioning. Journal of Sex & Marital Therapy 1987; 13:155-167

Page 9 of 22

 

51) Althof SE, Turner LA, Risen CB, Bodner DR, Kursh ED, Resnick MI. Side effects

of self-administration of intracavernosal injection of papaverine and phentolamine for treatment of impotence. Journal of Urology 1989; 141:54-7

52) Turner LA, Froman SL, Althof SE, Levine SB, Tobias TR, Kursh ED, Bodner DR.

Intracavernous injection in the management of diabetic impotence.  Journal of Sexual Education and Therapy 16(2):126-36, 1989

53) Is it time for sexual mental health centers? Journal of Sex & Marital Therapy 1989;
54) Althof SE, Turner LA, Levine SB, Risen CB, Bodner D, Kursh ED, Resnick MI.

Sexual, psychological, and marital impact of self injection of papaverine and

phentolamine: a long-term prospective study.  Journal of Sex & Marital Therapy
55) Althof SE, Turner LA, Levine SB, Risen CB, Bodner D, Kursh ED, Resnick MI.
Why do so many men drop out of intracavernosal treatment?   Journal of Sex &

Marital Therapy. 1989; 15:121-9

56) Turner LA, Althof SE, Levine SB, Risen CB, Bodner D, Kursh ED, Resnick MI. Self

injection of papaverine and phentolamine in the treatment of psychogenic impotence. Journal of Sex & Marital Therapy. 1989; 15(3):163-78

57) Turner LA, Althof SE, Levine SB, Risen CB, Bodner D, Kursh ED, Resnick MI.

Treating erectile dysfunction with external vacuum devices: impact upon sexual,
psychological, and marital functioning.  Journal of Urology 1990; 141(1):79-82

58) Risen CB, Althof SE.  An essay on the diagnosis and nature of paraphilia Journal of

Sex & Marital Therapy 1990; 16(2):89-102.

59) Althof SE, Turner LA, Levine SB, Risen CB, Bodner DB, Kursh ED, Resnick MI.

Through the eyes of women: the sexual and psychological responses of women to their partners’ treatment with self-injection or vacuum constriction therapy.
International Journal of Impotence Research (supplement 2)1990; 346-7.

60) Althof SE, Turner LA, Levine SB, Risen CB, Bodner DB, Kursh ED, Resnick MI. A

comparison of the effectiveness of two treatments for erectile dysfunction: self

injection vs. external vacuum devices. . International Journal of Impotence Research (supplement 2)1990; 289-90

61) Kursh E, Turner L, Bodner D, Althof S, Levine S. A prospective study on the use of

the vacuum pump for the treatment of impotence.International Journal of Impotence Research (supplement 2)1990; 340-1.

62) Althof SE, Turner LA, Levine SB, Risen CB, Bodner DB, Kursh ED, Resnick MI.

Long term use of intracavernous therapy in the treatment of erectile dysfunction in Journal of Sex & Marital Therapy 1991; 17(2):101-112

63) Althof SE, Turner LA, Levine SB, Risen CB, Bodner DB, Kursh ED, Resnick MI.

Long term use of vacuum pump devices in the treatment of erectile dsyfunction in Journal of Sex & Marital Therapy 1991;17(2):81-93

64) Turner LA, Althof SE, Levine SB, Bodner DB, Kursh ED, Resnick MI. A 12-month

 

Page 10 of 22

 

comparison of the effectiveness of two treatments for erectile dysfunction: self injection vs. external vacuum devices. Urology 1992;39(2):139-44

65) Althof SE, The pathogenesis of psychogenic impotence.  J. Sex Education and

Therapy. 1991; 17(4):251-66

66) Mehta P, Bedell WH, Cumming W, Bussing R, Warner R, Levine SB. Letter to the

editor. Reflections on hemophilia camp. Clinical Pediatrics 1991; 30(4):259-260

67) Successful Sexuality. Belonging/Hemophilia. (Caremark Therapeutic Services),

Autumn, 1991

68) Psychological intimacy. Journal of Sex & Marital Therapy 1991; 17(4):259-68

69) Male sexual problems and the general physician, Georgia State Medical Journal

1992; 81(5): 211-6

70) Althof SE, Turner LA, Levine SB, Bodner DB, Kursh E, Resnick MI. Through the

eyes of women: The sexual and psychological responses of women to their partner’s treatment with self-injection or vacuum constriction devices. Journal of Urology 1992; 147(4):1024-7

71) Curry SL, Levine SB, Jones PK, Kurit DM. Medical and Psychosocial predictors of

sexual outcome among women with systemic lupus erythematosis.  Arthritis Care and Research 1993;  6:23-30

72) Althof SE, Levine SB. Clinical approach to sexuality of patients with spinal cord

injury. Urological Clinics of North America 1993; 20(3):527-34

73) Gender-disturbed males. Journal of Sex & Marital Therapy 19(2):131-141, 1993 74) Curry SL, Levine SB, Jones PK, Kurit DM. The impact of systemic lupus

erythematosis on women’s sexual functioning. Journal of Rheumatology 1994; 21(12):2254-60

75) Althof SE, Levine SB, Corty E, Risen CB, Stern EB, Kurit D. Clomipramine as a

treatment for rapid ejaculation: a double-blind crossover trial of 15 couples. Journal of Clinical Psychiatry 1995;56(9):402-7

76) Risen CB, Althof SE. Professionals who sexually offend: evaluation procedures and

preliminary findings. Journal of Sex & Marital Therapy 1994; 20(4):288-302
77) On Love, Journal of Sex & Marital Therapy 1995; 21(3):183-191
78) What is clinical sexuality? Psychiatric Clinics of North America 1995; 18(1):1-6 79) “Love” and the mental health professions: Towards an understanding of adult love.
Journal of Sex & Marital Therapy 1996; 22(3)191-20

(a) Reprinted in Issues in Human Sexuality: Current & Controversial Readings with
Links to Relevant Web Sites, 1998-9, Richard Blonna, Editor, Engelwood, Co.

Morton Publishing Company, 1998

80) The role of Psychiatry in erectile dysfunction: a cautionary essay on the emerging

 

Page 11 of 22

 

treatments. Medscape Mental Health 2(8):1997 on the Internet. September, 1997.

81) Discussion of Dr. Derek Polonsky’s SSTAR presentation on Countertransference.
Journal of Sex Education and Therapy 1998; 22(3):13-17

82) Understanding the sexual consequences of the menopause. Women’s Health in
Primary Care, 1998

(a) Reprinted in the International Menopause Newsletter

83) Fones CSL, Levine SB. Psychological aspects at the interface of diabetes and erectile
dysfunction. Diabetes Reviews 1998; 6(1):1-8

84) Guay AT, Levine SB, Montague DK. New treatments for erectile dysfunction.
Patient Care March 15, 1998

85) Extramarital Affairs. Journal of Sex & Marital Therapy 1998; 24(3):207-216

86) Levine SB (chairman), Brown G, Cohen-Kettenis P, Coleman E, Hage JJ, Petersen
M,  Pfäfflin F, Shaeffer L, vanMasdam J, Standards of Care of the Harry Benjamin

International Gender Dysphoria Association, 5th revision, 1998. International Journal
of Transgenderism at http://www.symposion.com/ijt

(a) Reprinted by the  Harry Benjamin International Gender Dysphoria Association,
Minneapolis, Minnesota

87) Althof SE, Corty E, Levine SB, Levine F, Burnett A, McVary K, Stecher V, Seftel.

The EDITS: the development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999;53:793-799

88) Fones CSL, Levine SB, Althof SE, Risen CB. The sexual struggles of 23 clergymen:

a follow-up study. Journal of Sex & Marital Therapy 1999

89) The Newly Devised Standards of Care for Gender Identity Disorders. Journal of Sex

Education and Therapy 24(3):1-11,1999

90) Levine, S. B. (1999). The newly revised standards of care for gender identity

disorders. Journal of Sex Education & Therapy, 24, 117-127.

91) Melman A, Levine SB, Sachs B, Segraves RT, Van Driel MF. Psychological Issues

in Diagnosis of Treatment (committee 11) in Erectile Dysfunction (A.Jarden,

G.Wagner, S.Khoury, F. Guiliano, H.Padma-nathan, R. Rosen, eds.) Plymbridge Distributors Limited, London, 2000

92) Pallas J, Levine SB, Althof SE, Risen CB. A study using Viagra in a mental health

practice. J Sex&Marital Therapy.26(1):41-50, 2000

93) Levine SB, Stagno S. Informed Consent for Case Reports: the ethical dilemma

between right to privacy and pedagogical freedom. Journal of Psychotherapy: Practice and Research, 2001, 10 (3): 193-201.

94) Alloggiamento T., Zipp C., Raxwal VK, Ashley E, Dey S. Levine SB, Froelicher

  1. Sex, the Heart, and Sildenafil. Current Problems in Cardiology 26 June 2001(6):381-416

 

Page 12 of 22

 

95) Re-exploring The Nature of Sexual Desire. Journal of Sex and Marital Therapy
28(1):39-51, 2002.

96) Understanding Male Heterosexuality and Its Disorders in Psychiatric Times
XIX(2):13-14, February, 2002

97) Erectile Dysfunction: Why drug therapy isn’t always enough. (2003) Cleveland
Clinic Journal of Medicine, 70(3): 241-246.

98) The Nature of Sexual Desire: A Clinician’s Perspective.  Archives of Sexual
Behavior 32(3):279-286, 2003 .

99) Laura Davis. What I Did For Love: Temporary Returns to the Male Gender Role.
International Journal of Transgenderism, 6(4), 2002 and

http://www.symposion.com/ijt

100) Risen C.B., The Crisis in the Church: Dealing with the Many Faces of Cultural

Hysteria in The International Journal of Applied Psychoanalytic Studies, 1(4):364-
370, 2004

101) Althof SE, Leiblum SR (chairpersons), Chevert-Measson M. Hartman U., Levine

SB, McCabe M., Plaut M, Rodrigues O, Wylie K., Psychological and Interpersonal
Dimensions of Sexual Function and Dysfunction in World Health Organization
Conference Proceedings on Sexual Dysfunctions, Paris, 2003. Published in a book
issued in 2004.

102) Commentary on Ejaculatory Restrictions as a Factor in the Treatment of Haredi

(Ultra-Orthodox) Jewish Couples: How Does Therapy Work? Archives of Sexual Behavior, 33(3):June 2004

103) What is love anyway? J Sex & Marital Therapy 31(2):143-152,2005.

104) A Slightly Different Idea, Commentary on Y.M.Binik’s Should Dyspareunia Be

Retained as a Sexual Dysfunction in DSM-V? A Painful Classification Decision.
Archives of Sexual Behavior 34(1):38-39, 2005. http://dx.doi.org/10.1007/s10508-
005-7469-3

105) Commentary. Pharmacologic Treatment of Erectile Dysfunction: Not always a

simple matter. BJM USA; Primary Care Medicine for the American Physician, 4(6):325-326, July 2004

106) Leading Comment: A Clinical Perspective on Infidelity.  Journal of Sexual and

Relationship Therapy, 20(2):143-153, May 2005.

107) Multiple authors.  Efficacy and safety of sildenafil citrate (Viagra) in men with

serotonergic antidepressant-associated erectile dysfunction: Results from  a randomized, double-blind, placebo-controlled trial.  Submitted to Journal of Clinical Psychiatry Feb 2005

108) Althof SE, Leiblum SR, Chevert-Measson M, Hartman U,Levine SB,McCabe M,

Plaut M, Rodrigues O, Wylie K. Psychological and Interpersonal Dimensions of
Sexual Function and Dysfunction.  Journal of Sexual Medicine, 2(6): 793-800,

 

Page 13 of 22

 

November, 2005

109) Shifren JL, Davis SR, Moreau M, Waldbaum A, Bouchard C., DeRogatis L.,

Derzko C., Bearnson P., Kakos N., O’Neill S., Levine S., Wekselman K., Buch A.,
Rodenberg C., Kroll R. Testosterone Patch for the Treatment of Hypoactive Sexual
Desire Disorder in Naturally Menopausal Women: Results for the INTIMATE
NM1 Study.  Menopause: The Journal of the North American Menopause Society
13(5) 2006.

110) Reintroduction to Clinical Sexuality. Focus: A Journal of Lifelong Learning in

Psychiatry Fall 2005. III (4):526-531

111) PDE-5 Inhibitors and Psychiatry in J Psychiatric Practice 12 (1): 46-49, 2006.
112) Sexual Dysfunction: What does love have to do with it? Current Psychiatry

5(7):59-68, 2006.

113) How to take a Sexual History (Without Blushing), Current Psychiatry 5(8): August,

114) Linking Depression and ED:  Impact on sexual function and relationships in Sexual

Function and Men’s Health Through the Life Cycle under the auspices of the

Consortium for Improvement of Erectile Function (CIEF),12-19, November, 2006. 115) The First Principle of Clinical Sexuality.  Editorial. Journal of Sexual
Medicine,4:853-854, 2007

116) Commentary on David Rowland’s editorial, “Will Medical Solutions to Sexual

Problems Make Sexological Care and Science Obsolete?” Journal of Sex and Marital Therapy, 33(5), 2007 in press

117) Real-Life Test Experience: Recommendations for Revisions to the Standards of

Care of the World Professional Association for Transgender Health International Journal of Transgenderism, Volume 11 Issue 3, 186-193, 2009

118) Sexual Disorders: Psychiatrists and Clinical Sexuality.  Psychiatric Times XXIV

(9), 42-43, August 2007

119) I am not a sex therapist! Commentary to I. Binik and M. Meana’s article Sex

Therapy: Is there a future in this outfit? Archives of Sexual Behavior, Volume 38, Issue 6 (2009),  1033-1034

120) Solomon A (2009) Meanings and Political Implications of “Psychopathology”  in a

Gender Identity Clinic: Report of 10 cases. Journal of Sex and Marital Therapy 35(1): 40-57.

121) Perelman, MA., Levine SB, Fischkoff SA. Randomized, Placebo-Controlled,

Crossover Study to Evaluate the Effects of Intranasal Bremelanotide on Perceptions of Desire and Arousal in Postmenopausal Women with Sexual Arousal Disorder submitted to Journal of Sexual Medicine July 2009, rejected

122) What is Sexual Addiction? Journal of Sex and Marital Therapy.2010

 

Page 14 of 22

 

May;36(3):261-75

123) David Scott (2010) Sexual Education of Psychiatric Residents.  Academic

Psychiatry, 34(5) 349-352.

124) Chris G. McMahon, Stanley E. Althof, Joel M. Kaufman, Jacques Buvat, Stephen

  1. Levine, Joseph W. Aquilina, Fisseha Tesfaye, Margaret Rothman, David A. Rivas, Hartmut Porst. Efficacy and Safety of Dapoxetine for the Treatment of Premature Ejaculation: Integrated Analysis of Results From 5 Phase 3 Trials Journal of Sexual Medicine 2011 Feb;8(2):524-39.

125) Commentary on Consideration of Diagnostic Criteria for Erectile Dysfunction in

DSM V.  Journal of Sexual Medicine July 2010

126) Hypoactive Sexual Desire Disorder in Men: Basic types, causes, and treatment.

Psychiatric Times 27(6)4-34. 2010

127) Male Sexual Dysfunctions, an audio lecture, American Physician Institute 2013
128) Fashions in Genital Fashion: Where is the line for physicians? Commentary on

David Veale and Joe Daniels’ Cosmetic Clitoridectomy in a 33-year-old woman. Archives of Sexual Behavior, epub ahead of print Sept 24, 2011. Arch Sex Behav (2012) 41:735-736     DOI 10.1007/s10508-011-9849-7

129) Review: Problematic Sexual Excess.  Neuropsychiatry 2(1):1-12, 2012
130) The Essence of Psychotherapy.  Psychiatric Times 28 (2): August 2, 2012

translated into Portuguese and republished in Revista Latinoamericana de Psicopatologia Fundamental (latin-American Journal of Fundamental Psychopathology) in press 2012.

131) Parran TV, Pisman, AR, Youngner SJ, Levine SB.Evolution of remedial CME

course in professionalism: Addressing learner needs, developing content, and

evaluating outcomes. Journal of Continuing Education in the Health Professions, 33(3): 174-179, 2013.

132) Love and Psychiatry.  Psychiatric Times November 2013

133) Orgasmic Disorders, Sexual Pain Disorders, and Sexual Dysfunction Due to a

Medical Condition.  Board Review Psychiatry 2013-2014 Audio Digest CD 27. Audio recording of a one-hour lecture available October 2013.

134) Towards a Compendium of the Psychopathologies of  Love.  Archives of Sexual

Behavior Online First December 25, 2013 DOI 10.1007/s10508-013-0242-6 43(1)213-220.

135) Flibanserin. (editorial) Archives of Sexual Behavior 44 (8), 2015 November 2015.

DOI: 10.1007/s10508-015-0617-y

136) Martel C, Labrie F, Archer DF, Ke Y, Gonthier R, Simard JN, Lavoie L,

Vaillancourt M, Montesino M, Balser J, Moyneur É; other participating members
of the Prasterone Clinical Research Group. (2016) Serum steroid concentrations

 

Page 15 of 22

 

remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.J Steroid Biochem Mol Biol. 2016
May;159:142-53. doi: 10.1016/j.jsbmb.2016.03.016

137) Reflections of an Expert on the Legal Battles Over Prisoners with Gender

Dysphoria.  J Am Acad Psychiatry Law 44:236-45, 2016

138) Cooper E, McBride J, Levine SB.  Does Flibanserin have a future?  Psychiatric

Times accepted October 23, 2015.

139) Levine SB, Sheridan DL, Cooper EB. The Quest for a Prosexual Medication for

Women, Current Sexual Health Reports (2016) 8: 129. doi:10.1007/s11930-016-
0085-y

140) Why Sex Is Important: Background for Helping Patients with Their Sexual Lives.,

British Journal of Psychiatry Advances (2017), vol. 23(5) 300-306; DOI:

10.1192/apt.bp.116.016428

141) Flibanserin: Offene Forshungsfragen , Zeitschrift für Sexualforschung. 29:

170-175, 2016. This is a translation of (134).

142) Commentary on  “Asexuality: Orientation, paraphilia, dysfunction, or none

of the above? Archives Sexual Behavior, Archives of Sexual Behavior April 2017,
Volume 46, Issue 3, pp 639-642 DOI: 10.1007/s10508-017-0947-z

143) Sexual Dysfunction in Clinical Psychiatry, Psychiatric Times, March 2017

144) Ethical Concerns About the Emerging Treatment of Gender Dysphoria. Journal of

Sex and Marital Therapy, 44(1):29-44. 2017. DOI

10.1080/0092623X.2017.1309482

145) The Psychiatrist’s Role in Managing Transgender Youth: Navigating Today’s

Politicized Terrain. CMEtoGO® Audio Lecture Series, May 2017

146) Transitioning Back to Maleness, Archives of Sexual  Behavior, 2017 Dec           20.

doi: 10.1007/s10508-017-1136-9. [Epub ahead of print]; 47(4), 1295-1300, May
2018

147) Informed Consent for Transgender Patients, Journal of Sex and Marital Therapy,

2018 Dec 22:1-12. doi: 10.1080/0092623X.2018.1518885. [Epub ahead of print]

  1. C) Chapters

1)   Overview of Sex Therapy. In Sholevar GP (ed) The Handbook of Marriage and
Marital Therapy. New York. Spectrum Publications, 1981 pp417-41

2)   Why study sexual functioning in diabetes? In Hamburg BA, Lipsett LF, Inoff GE,
Drash A (eds) Behavioral & Psychosocial Issues in Diabetes: Proceedings of a

National conference. Washington, DC. US Dept. of Health & Human Services. PHS NIH, Pub. #80-1933

3)   Sexual Problems in the Diabetic in Bleicher SJ, Brodoff B (eds) Diabetes Mellitus
and Obesity. Williams and Wilkins, 1992

 

Page 16 of 22

 

4)    Clinical Introduction to Human Sexual Dysfunction. In Pariser SF, Levine SB,

McDowell M (eds) Clinical Sexuality. New York, Marcel Dekker Publisher, 1983. 5) Psychodynamically-oriented clinician’s overview of psychogenic impotence. In RT
Segraves (ed) Impotence. New York, Plenum, 1985

6)    Origins of sexual preferences. In Shelp EE (ed) Sexuality and Medicine. D. Reidel

Publishing co. 1987. Pp39-54.

7)    Hypoactive Sexual Desire and Other Problems of Sexual Desire. In H. Lief (ed). The

Treatment of Psychosexual Dysfunctions/ III. American Psychiatric Press, chapter 207.pp2264-79, 1989

8)    Psychological Sexual Dysfunction. In Sudak H (ed) Clinical Psychiatry. Warren H.

Green. St. Louis, 1985

9)    Male sexual dysfunction. In Sudak H (ed) Clinical Psychiatry. Warren H. Green. St.

Louis, 1985

10) Sexuality and Aging. In Sudak H (ed) Clinical Psychiatry. Warren H. Green. St.

Louis, 1985

11) Homosexuality. In Sudak H (ed) Clinical Psychiatry. Warren H. Green. St. Louis,

1985

12) Individual and intrapsychic factors in sexual desire. In Leiblum SR, Rosen RC (eds).

Clinical Perspectives on Sexual Desire Disorders. Guilford Press, New York, 1988,
pp21-44

13) Gender Identity Disorders. In Sadock B, Kaplan H(eds). Comprehensive Textbook of

Psychiatry, Baltimore, William and Wilkins, 1989, pp 1061-9

14) Intrapsychic and Interpersonal Aspects of Impotence: Psychogenic Erectile

Dysfunction. In Leiblum SR, Rosen RC (eds). Erectile Disorders: Assessment and Treatment. Guilford Press, New York, 1992

15) Psychological Factors in Impotence.  In Resnick MI, Kursh ED, (eds.) Current

Therapy in Genitourinary Surgery, 2nd edition. BC Decker, 1991, pp549-51

16) The Vagaries of Sexual Desire. In Leiblum SR, Rosen RC (eds). In Case Studies in

Sex Therapy. Guilford Press, New York, 1995

17) Rosenblatt EA. Sexual Disorders (chapter 62). In Tasman A, Kay J, Liberman JA

(eds). Psychiatry Volume II, W.B.Saunders, Philadelphia. 1997, pp 1173-2000.

18) Althof SE. Psychological Evaluation and Sex Therapy. In Mulcahy JJ (ed) Diagnosis

and Management of Male Sexual Dysfunction Igaku-Shoin, New York, 1996, pp74-
88

19) Althof SE, Levine SB. Psychological Aspects of Erectile Dysfunction. In Hellstrum

WJG (ed) Male Infertility and Dysfunction. Springer-Verlag, New York, 1997. pp
468-73

20) Paraphilias. In Comprehensive Textbook of Psychiatry/VII. Sadock BJ, Sadock VA

 

Page 17 of 22

 

(eds.) Lippincott Williams & Wilkins, Baltimore, 1999, pp1631-1645.

21) Women’s Sexual Capacities at Mid-Life in The Menopause: Comprehensive

Management B. Eskind (ed). Parthenon Publishing, Carnforth, UK, 2000.

22) Male Heterosexuality in Masculinity and Sexuality:Selected Topics in the

Psychology of Men, (Richard C. Friedman and Jennifer I. Downey, eds) Annual

Review of Psychiatry, American Psychiatric Press, Washington, DC, W-18. pp29-54.

23) R.T.Segraves. Introduction to section on Sexuality: Treatment of Psychiatric

Disorders-III (G.O.Gabbard, ed), American Psychiatric Press, Washington, DC, 2001 24) Sexual Disorders (2003) in Tasman A, Kay J, Liberman JA (eds). Psychiatry 2nd
edition, Volume II, W.B.Saunders, Philadelphia. Chapter 74

25) What Patients Mean by Love, Psychological Intimacy, and Sexual Desire (2003) in

SB Levine, CB Risen, SE Althof (eds) Handbook of Clinical Sexuality for Mental Health Professionals, Brunner-Routledge, New York, pp.21-36.

26) Infidelity (2003) in SB Levine, CB Risen, SE Althof (eds) Handbook of Clinical

Sexuality for Mental Health Professionals, Brunner-Routledge, New York, pp57-74
27) Preface (2003) in SB Levine, CB Risen, SE Althof (eds) Handbook of Clinical
Sexuality for Mental Health Professionals, Brunner-Routledge, New York, pp xiii-

xviii

28) A Psychiatric Perspective on Psychogenic Erectile Dysfunction (2004) in T.F. Lue

(ed) Atlas of Male Sexual Dysfunction, Current Medicine, Philadelphia Chapter 5
29) Levine, SB., Seagraves, RT.  Introduction to Sexuality Section, Treatment of
Psychiatric Disorders, 3rd edition (Gabbard GO, editor), American Psychiatric Press,

2007

30) Risen CB, (2009)Professionals Who Are Accused of Sexual Boundary Violations In

Sex Offenders: Identification, Risk Assessment, Treatment, and Legal Issues edited by Fabian M. Saleh, Albert J. Grudzinskas, Jr., and John M. Bradford, Oxford University Press, 2009

31) What Patients Mean by Love, Intimacy, and Sexual Desire, in Handbook of Clinical

Sexuality for Mental Health Professionals edited by Levine SB, Risen, CB, and Althof, SE, Routledge, New York, 2010

32) Infidelity in Handbook of Clinical Sexuality for Mental Health Professionals edited

by Levine SB, Risen, CB, and Althof, SE, Routledge, New York, 2010

33) Scott DL, Levine, SB.  Understanding Gay and Lesbian Life in Handbook of Clinical

Sexuality for Mental Health Professionals edited by Levine SB, Risen, CB, and Althof, SE, Routledge, New York, 2010

34) Levine, SB, Hasan, S., Boraz M. (2009) Male Hypoactive Sexual Desire Disorder

(HSDD) in Clinical Manual of Sexual Disorders (R. Balon and RT Segraves, eds), American Psychiatric Press, Washington, DC.

 

Page 18 of 22

 

35) Levine, SB. Sexual Disorders in  Fundamentals of Psychiatry (by Allan Tasman and

Wanda Mohr,eds.) http://eu.wiley.com/WileyCDA/WileyTitle/productCd-
0470665777.html

36) Infidelity in Principles and Practices of Sex Therapy (I Binik, K. Hall, editors), 5th

edition, Guilford Press, New York, 2014.

37) Why is Sex Important? In Handbook of Clinical Sexuality for Mental Health

Professionals 3rd ed. [SB Levine, CB Risen, SE Althof, eds] New York. Routledge, 2016, Chapter 1

38) The Rich Ambiguity of Key Terms: Making Distinctions. In Handbook of Clinical

Sexuality for Mental Health Professionals 3rd ed. [SB Levine, CB Risen, SE Althof, eds] New York. Routledge, 2016. Chapter 4

39) The Mental Health Professional’s Treatment of Erection Problems . In Handbook of

Clinical Sexuality for Mental Health Professionals 3rd ed. [SB Levine, CB Risen, SE Althof, eds] New York. Routledge, 2016 Chapter 11

40)   Why is Sex Important? In Sexual Health in the Couple: Management of Sexual

Dysfunction in Men and Women [L Lipshultz, A Pastuszak, M Perelman, A Giraldi, J Buster, eds.] New York, Springer, 2016.

41) Sommers, B., Levine, S.B., Physician’s Attitude Towards Sexuality; Psychiatry and

Sexual Medicine: A Comprehensive Guide for Clinical Practitioners, in press 2019

42) Boundaries And The Ethics Of Professional Misconduct in A. Steinberg, J. L. Alpert,

C A. Courtois( Eds.) Sexual Boundary Violations In Psychotherapy:Therapist Indiscretions, & Transgressions, & Misconduct American Psychological
Association, In Press 2019

  1. D) Book Reviews

1)    Homosexualities: A Study of Diversity Among Men and Women by Alan P. Bell and

Martin S. Weinberg, Simon and Schuster, New York, 1978. In Journal of Sex & Marital Therapy 1979; 5:

2)    Marriage and Marital Therapies: Psychoanalytic, Behavioral & System Theory

Perspectives by TJ Paolino and BS McCrady. Brunner/Mazel, New York, 1978. In Journal of Sex & Marital Therapy 1979; 5:

3)    Management of Male Impotence. Volume 5 International Perspectives in Urology

AH Bennett, (ed) Williams and Wilkins, Baltimore, 1992. In American Journal of Psychiatry, 1984

4)    The Sexual Relationship by DE Scharff, Routledge & Kegan Paul, 1982 in Family

Process 1983;22:556-8

5)    Phenomenology and Treatment of Psychosexual Disorders, by WE Fann, I Karacan,

AD Pokorny, RL Williams (eds). Spectrum Publications, New York, 1983. In American Journal of Psychiatry 1985;142:512-6

 

 

Page 19 of 22

 

6)    The Treatment of Sexual Disorders: Concepts and Techniques of Couple Therapy, G

Arentewicz and G Schmidt. Basic Books, New York, 1983. In  American Journal of Psychiatry 1985;142:983-5

7)    Gender Dysphoria: Development, Research, Management. BN Steiner (ed). Plenum

Press, 1985 in Journal of Clinical Psychiatry, 1986

8)    Gender Dysphoria: Development, Research, Management. BN Steiner (ed). Plenum

Press, 1985 in Contemporary Psychology 1986:31:421-2 [titled, The Limitations of Science, the Limitations of Understanding]

9)    Psychopharmacology of Sexual Disorders by M Segal (ed) John Libbey & Co Ltd,

London, 1987 in American Journal of Psychiatry 1987;144:1093

10) “The Sissy Boy Syndrome” and the Development of Homosexuality by R Green.

Yale University Press, New Haven, 1987. In  American Journal of Psychiatry 1988;145:1028

11) Male Homosexuality: A contemporary psychoanalytic perspective by RC Friedman,

Yale University Press, New Haven, 1988 in Journal of Clinical Psychiatry 1989;50:4, 149

12) Sexual Landscapes: Why we are what we are, why we love whom we love. By JD

Weinrich, Charles Schribner’s Sons, New York, 1987 in Archives of Sexual Behavior 21 (3):323-26, 1991

13) How to Overcome Premature Ejaculation by HS Kaplan, Brunner/Mazel, New York,

1989 in Journal of Clinical Psychiatry 51(3):130, 1990

14) Clinical Management of Gender Identity Disorders in Children and Adults R.

Blanchard, BN Steiner (eds) American Psychiatry Press, Washington, DC, 1990. In Journal of Clinical Psychiatry 52(6):283, 1991

15) Psychiatric Aspects of Modern Reproductive Technologies. NL Stotland (ed)

American Psychiatric Press, Washington DC, 1990. In Journal of Clinical Psychiatry 1991;52(9):390

16) Homosexualities: Reality, Fantasy, and the Arts. CW Socarides, VD Volkan (eds).

International Universities Press, Madison, Connecticut, 1990. In Journal of Clinical Psychiatry 1992;(10)

17) Reparative Therapy of Male Homosexuality: A New Clinical Approach.  J Nicolosi,

Jason Aronson, Northvale NJ, 1992. In Contemporary Psychology 38(2):165-6, 1993 [entitled Is Evidence Required?]

18) Male Victims of Sexual Assault, GC Mezey, MB King (eds) Oxford University

Press, New York, 1992. In Journal of Clinical Psychiatry 1993;54(9):358,

19) AIDS and Sex: An Integrated Biomedical and Biobehavioral Approach. B Voeller,

JM Reinisch, M Gottlieb, Oxford University Press, New York, 1990. In American Journal of Psychiatry

 

 

Page 20 of 22

 

20) Porn: Myths for the Twentieth Century by RJ Stoller, Yale University Press, New

Haven, 1991. In Archives of Sexual Behavior 1995;24(6):663-668

21) Sexual Dysfunction: Neurologic, Urologic, and Gynecologic Aspects. R

Lechtenberg, DA Ohl (eds) Lea & Febiger, Philiadelphia, 1994. In Neurology
22) The Sexual Desire Disorders: Dysfunctional Regulation of Sexual
23) Motivation. HS Kaplan Brunner/Mazel, New York, 1995. In Neurology
1996; 47:316

24) Femininities, Masculinities, Sexualities: Freud and Beyond. N. Chodorow. The

University Press of Kentucky, Lexington, 1994. Archives of Sexual Behavior 28(5):397-400,1999

25) Sexual Function in People with Disability and Chronic Illness:A Health

Professional’s Guide by ML Sipski, CJ Alexander. Aspen Publishers, Gaitersburg, Md, 1997. In Journal of Sex Education and Therapy, 1998;23(2):171-2

26) Sexual Aggression by J Shaw (ed). American Psychiatric Press, Washington, DC,

  1. In American Journal of Psychiatry, May, 1999

27) The Wounded Healer: Addiction-Sensitive Approach to the Sexually Exploitative

Professional by Richard Irons and Jennifer P. Schneider. Jason Aronson, Northvale, N.J., 1999 in American Journal of Psychiatry 157(5):8-9,2000.

28) Culture of the Internet by Sara Kiesler (editor), Lawrence Erlbaum Associates,

Mahway, New Jersey, 1997. 463pp in Journal of Sex Research in press, 2001

29) Psychological Perspectives on Human Sexuality. Lenore T. Szuchman and Frank

Muscarella (editors), Wiley and Sons, New York, American Journal of Psychiatry, April, 2002

30) “How Sexual Science Operates” a review of Sex, Love, and Health in America:

Private Choices and Public Policies. EO Laumann and RT Michael, editors. Chicago, University of Chicago, 2001 in Second Opinion, The Park Ridge Center for the
Study of Health, Faith, and Ethics, 11:82-3, April, 2004.

31) Sexual Orientation and Psychoanalysis: Sexual Science and Clinical Practice.

R.C.Friedman and J.I. Downey (eds). New York. Columbia University Press. in Archives of Sexual Behavior (2003) 31(5):473-474

32) Prozac on the Couch:  Prescribing Gender in the Era of Wonder Drugs, Jonathon

Michel Metzl.  Duke University Press, Durham, 2003 in American Journal of Psychiatry, November, 2004.

33) Sex and Gender by M. Diamond and A.Yates Child Psychiatric Clinics of North

America W. B. Saunders, Philadelphia, Pennsylvania, 2004, 268 pp in Archives of
Sexual Behavior April 2007 on line publication in Dec.2006 at
http://dx.doi.org/10.1007/s10508-006-9114-7

34) Getting Past the Affair: A program to help you cope, heal, and move on—together or

 

Page 21 of 22

 

apart by Douglas K. Snyder, Ph.D, Donald H. Baucom, Ph.D, and Kristina Coop Gordon, Ph.D, New York, Guilford Press, 2007 in Journal of Sex and Marital Therapy,34:1-3, 2007

35) Dancing with Science, Ideology and Technique. A review of Sexual Desire

Disorders: A casebook Sandra R. Leiblum editor, Guilford Press, New York, 2010. In Journal of Sex Research 2011.

36) What is more bizarre: the transsexual or transsexual politics?  A review of Men

Trapped in Men’s Bodies: Narratives of Autogynephilic Transsexualism by Anne A.
Lawrence, New York, Springer, 2014. In Sex Roles: a Journal of Research, 70, Issue

3 (2014), Page 158-160, 2014. DOI: 10.1007/s11199-013-0341-9

37) There Are Different Ways of Knowing.  A review of: How Sexual Desire Works:

The Enigmatic Urge by Frederick Toates, Cambridge, UK, Cambridge University

Press, in Sexuality and Cu1ture (2015) 19:407-409 DOI 10.1007/s12119-015-9279-
0

38) The Dynamics of Infidelity: Applying Relationship Science to Clinical Practice by

Lawrence Josephs, American Psychological Association, Washington, DC, 2018, pp. 287, $69.95   in Journal of Sex and Marital Therapy

10.1080/0092623X.2018.1466954,  2018.  For free access:

https://www.tandfonline.com/eprint/UgiIHbWbpdedbsXWXpNf/full

39) Transgender Mental Health by Eric Yarbrough, American Psychiatric Association

Publications, 2018, Journal and Marital & Sexual Therapy,

https://doi.org/10.1080/0092623X.2018.1563345 .

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Page 22 of 22

Hits: 2

Scroll to Top